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ABSTRACT
Respiratory diseases in horses and calves often result in reduced performance. Infective
respiratory diseases are considered important in both animal species, but allergic-type
diseases are historically more relevant in horses. Respiratory air quality unquestionably
also exerts an impact on food production animals. The aim of this thesis was to investigate
environmental dust-induced elevation in gelatinolytic matrix metalloproteinase (MMP)
levels in the equine airways and in calves with pulmonary bacterial infection. Proteolytic
degradation of airway tissue by MMPs has previously been found to correlate with severity
of equine heaves or currently recurrent airway obstruction (RAO), and MMPs have been
used as biochemical indicators of inflammation.
Bronchoalveolar lavage fluid (BALF) of control and heaves-susceptible horses and
tracheobronchial lavage fluid (TBLF) of calves with microbial respiratory infection and
control calves were analysed for gelatinolytic MMPs (MMP-2 and MMP-9) and the degree
of activation of these gelatinases using zymography. The same method was employed in
an in vitro study of proMMP-9 activation capacity of allergens. Gelatinolytic bands were
identified by molecular weight, Western immunoblot and/or inhibition by
ethylenediaminetetraacetic acid (EDTA). Thus, total gelatinolytic activity, complex forms,
proMMP-9, active MMP-9, activation percentage of MMP-9, proMMP-2 and active
MMP-2 were analysed.
Consistent with previous studies, 92-kDa MMP-9 was the major gelatinolytic enzyme
detected. The activation of MMP-9 correlated with mould contamination of inhaled air.
MMP-2 was elevated in bacterial infection and also increased with mould inhalation.
BALF MMP-9 elevation was dose-dependent in both heaves and control horses following
inhalation challenges with hay dust suspension (HDS), endotoxin (LPS) and Aspergillus
fumigatus extract (AFE) (the last challenge was conducted with heaves-susceptible horses
only). LPS was found to cause the  clearest gelatinolytic elevations. HDSs with different
glucan and endotoxin contents caused varying increases in BALF gelatinolytic activities.
Mould contamination of HDS, reflected by its glucan concentration, seems to determine
the type of gelatinolytic profile detectable in BALF. Soluble and particulate fractions of
HDS failed to significantly increase gelatinolytic activity when assessed separately, but in
combination the elevations were comparable with those obtained by inhalation of whole
HDS, indicating a synergistic effect of glucan and endotoxin as tissue-destruction inducers.
Activation of MMP-9 was more enhanced following mould-containing challenges (AFE
and HDS with higher glucan concentration). This was further confirmed and extended
by in vitro studies using AFE-1 and AFE-2, washed particles of HDS (WP), wash fluid
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of WP (WF), supernatant of HDS (SUP), HDS and mite extract (MITE) as direct
activators of 92-kDa proMMP-9. The two AFEs and MITE were shown to be the most
potent activators of 92-kDa proMMP-9 in vitro.
TBLF from calves with clinical symptoms of respiratory disease and positive Pasteurella
and Mycoplasma sp. cultures of TBLF samples as well as six healthy controls were analysed
for gelatinolytic MMPs. Active MMP-2 and active MMP-9 levels were higher in TBLF
of calves with microbial respiratory infection than in controls. Pasteurella bacteria cultured
from TBLF samples were then disintegrated and underwent a similar analysis for gelatinolytic
MMPs. Blood agar-cultured Pasteurella did not express gelatinolytic proteinases. The
involvement of MMP-2 and MMP-9 in airways of calves with microbial respiratory
infection may be important in development of lung lesions, and thus, inhibition of these
enzymes may offer a new therapeutic means of treating respiratory infections in calves.
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1. INTRODUCTION
Heaves, currently called recurrent airway obstruction (RAO), is a common disease in
horses in Finland and in other countries where horses are kept mainly indoors. Heaves is
a chronic allergic-type inflammation of the lungs that results from recurring inhalation
of environmental allergens, mainly organic dust, and characterized by neutrophilia in
bronchoalveolar lavage fluid (BALF) (Derksen et al. 1985; McGorum et al. 1993a). Heaves
has traditionally been considered to be analogous to human asthma. The main difference
between these two diseases is that asthma is a merely eosinophilic condition, while heaves
leads to accumulation of neutrophils in the lungs. Infiltration of neutrophils appears to
be more dependent on elastases than matrix metalloproteinases (MMPs) in humans
(Kumagai et al. 1999).
In humans, a wide variety of respiratory air allergens has been reported; outdoor allergens
predominantly include plant pollens and fungal spores, and indoor allergens comprise
dust mites, dust from house pets and fungal spores (Kurup et al. 2000). Components of
organic dust play an important role in the pathogenesis of pulmonary disease in humans
(Michel et al. 1997; Vogelzang et al. 1998; Thorn 1999) and in animals (Fogelmark et
al. 1994; Jolie et al. 1999; George et al. 2001; Pirie et al. 2001). The two major irritating
components of organic dust are bacterial endotoxin from Gram-negative bacteria and
(1  >3)-β-D-glucan (glucan) from mould cell walls (Rylander 2001).
Exposure to endotoxin and its purified derivate lipopolysaccharide (LPS) is used widely
to study airway irritation and inflammation in experimental animals (D’Ortho et al. 1994;
Fogelmark et al. 1994; Ferry et al. 1997; Betsuyaku et al. 1999; Corbel et al. 2001a; Kang
et al. 2001; Moreland et al. 2001; Vernooy et al. 2002) and in humans (Jagielo et al. 1996;
Michel et al. 1997; Kline et al. 1999; O’Grady et al. 2001). Endotoxin has also been used
in in vitro models to stimulate cultured cells to produce pro-inflammatory mediators (Yao
et al. 1997; Palmberg et al. 1998). Inhaled LPS challenge has been shown to increase
neutrophil numbers in respiratory secretions of humans (Jagielo et al. 1996; Michel et al.
1997; Thorn and Rylander 1998a; O’Grady et al. 2001), experimental animals (D’Ortho
et al. 1994) and horses (Pirie et al. 2001). Response to inhalation of LPS is dose-dependent
in humans, as assessed by clinical symptoms, lung function tests and neutrophil and
cytokine levels in respiratory secretions (Jagielo et al. 1996; Michel et al. 1997; Palmberg
et al. 1998; Kline et al. 1999). Glucan has a synergistic pro-inflammatory effect with
endotoxin on airway inflammation (Fogelmark et al. 1994; Pirie et al. 2002a,b; Young
et al. 2002). A relationship between exposure to glucan and severity of airway inflammation
symptoms exists at least in humans (Rylander 1997a). The effect of exposure on development
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of airway symptoms has been extensively investigated from the viewpoint of human
occupational health (Castellan et al. 1984) and indoor air quality (Rylander 1996; Thorn
and Rylander 1998b).
Enzootic pneumonia of young calves is an important disease worldwide. The disease is
multifactorial and is often initiated by viruses. Allergic, heaves-type diseases are historically
considered not to occur in bovine species (von Fellenberg et al. 1979), but allergic,
hypersensitivity pneumonia has been recognized in cattle (Pearson 1984). Moreover,
farmers have an increased prevalence of allergic and toxic respiratory diseases due to dust
contamination of air in animal-rearing units (Malmberg 1990). Pasteurella and Mannheimia
infections are known to be synergistic with viral infections (Yates et al. 1983a; Narita et
al. 2000), and P. multocida alone can cause lung infection (Jericho and Carter 1984).
Calf-rearing units may offer good facilities for spread of respiratory pathogens, as calves
from different farms are gathered together while being stressed from transportation.
Neutrophil accumulation is typical in acute Pasteurella / Mannheimia infection of calves
(Slocombe et al. 1985; Weiss et al. 1991; Narita et al. 2000). Neutrophils secrete a variety
of enzymes involved in cell migration (Campbell et al. 1987), but the targets of their
proteolytic enzymes are relatively non-specific (Weiss 1989; Palmgren et al. 1992). An
association between neutrophils and tissue destruction was shown by Slocombe et al.
(1985). Tissue destruction in lungs was diminished after depletion of neutrophils in the
acute phase of inflammation. In previous studies on the pathogenesis and inflammation
process of Mannheimia infection, experimental animals have mainly been used (Yates et
al. 1983a; Jericho 1989; Narita et al. 2000; Reeve-Johnson 2001), and the research has
typically focused on the synergistic effects of viral and bacterial infections.
MMPs are proteases produced by recruited inflammatory cells and resident local tissue
cells. MMPs can be divided into the following subgroups: collagenases, gelatinases,
stromelysins, membrane-type MMPs and other MMPs. MMPs are cation/zinc-dependent
and can be inhibited by chelating agents. They are secreted in latent form and activated
by cleavage of a small peptide (Birkedal-Hansen 1995). MMPs are associated with normal
tissue remodelling, including wound healing and embryogenesis (Mainardi et al. 1991).
They have also been extensively studied in conjunction with diseases causing pathologically
excessive extracellular matrix destruction such as cancer (Gilles et al. 1997; Paguette et
al. 2003), rheumatoid arthritis (Kähäri and Saarialho-Kere 1999), periodontal disease
(Sorsa et al. 2004), skin and eye diseases (Kähäri and Saarialho-Kere 1999) and tissue
ulcerations (Holopainen et al. 2003).
Gelatinase A (72-kDa MMP-2) and gelatinase B (92-kDa MMP-9) have been shown in
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several studies to be associated with tissue destruction in allergic airway disease models,
where allergen inhalation creates symptoms similar those of asthma in humans (Michel
et al.1997; O’Grady et al. 2001) and in laboratory animals (Kumagai et al. 1999; Corbel
et al. 2001a; Nevalainen et al. 2002). In allergic respiratory diseases of animals, MMP-9
has been studied in heaves horses, where it has been demonstrated to be a good marker
of inflammation (Raulo et al. 2001a; Nevalainen et al. 2002). In infective respiratory
diseases of animals, MMP-9 and MMP-2 are elevated in pigs following porcine reproductive
and respiratory syndrome virus (PRRSV) infection (Girard et al. 2001) and in dogs
following canine pulmonary eosinophilia (Rajamäki et al. 2002). Furthermore, elevated
MMP levels have been detected in bovine mastitis (Raulo et al. 2002).
Equine heaves and calf pasteurellosis cause considerable financial losses: in horses, in the
form of early retirement from sports, decreased performance and increased medication
costs, and in calves in reduction in growth and increased medical costs. While infectious
diseases are considered more important in calves, environmentally induced airway diseases
can also have an impact. Animal shelter dust has recently been under intensive investigation
to clarify the occupational health impact on farmers (Malmberg 1990; Palmberg et al.
1998; Vogelzang et al. 1998; Schayck 2000); air quality likely also has an effect on calves.
Understanding airway response to environmental factors will aid in developing new ways
to diagnose, treat and prevent such pulmonary diseases as equine heaves. Both quantitative
and qualitative information is required to determine which dust components are harmful
in the air and should thus be minimized in the animals’ environment. Inhibition of MMPs
in airways, in turn, may provide additional opportunities to treat both allergic and infectious
airway diseases. Doxycycline and some chemically modified tetracyclines have recently
been proven to act as MMP inhibitors (Golub et al. 1997, 1998; Carney et al. 2001;
Emingil et al. 2004a,b). Tetracyclines have traditionally been successfully used to treat calf
pasteurellosis, suggesting that the antibiotic effect is not the only mode of action of these
drugs in curing these diseases. Deeper knowledge of the pathogenesis and modes of tissue
destruction will help to diagnose, control and treat both infective and allergic airway
diseases. Heaves horses exposed to airborne organic stable dust serve as excellent models
for studying in vivo respiratory inflammation caused by environmental exposure to
respiratory tract-irritating agents because of the sensitivity of their respiratory tract to
allergens and the possibility of obtaining large sample volumes.
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2. REVIEW OF THE LITERATURE
2.1 Equine heaves
Heaves, or recurrent airway obstruction (RAO) is one of the most important diseases
causing poor performance in racehorses. It also results in reduced use of leisure horses and
increased medication costs. As heaves is a progressive disease, it may eventually lead to
euthanasia of an affected horse (Robinson 2001). Although no published research exist
on the occurrence of equine heaves in Finland, it is often seen in practice. Heaves typically
occurs in countries where horses are stabled throughout the year. In a study of adult horses
in Northern Britain, 54.8% of horses referred to pulmonary examination had heaves, and
the second most common disease was infectious pulmonary disease (16.7%) (Dixon et
al. 1995). The disease usually affects middle-aged (>7 years) horses (Robinson 2001).
2.1.1. Pathogenesis of equine heaves
Diet (Clarke and Madelin 1987; Woods et al. 1993), previous infections (especially viral)
(Gerber 1973), genetic predisposition (Marti et al. 1991) and inhaled allergens (e.g. the
moulds Aspergillus fumigatus and Faenia rectivirgula, previously Microsporum faeni)
(McPherson et al. 1979; McGorum et al. 1993a) are all believed to cause heaves. The chief
agent(s) may vary geographically and with the type of stabling (McPherson and Thomson
1983; Beech 1991). Components of organic dust (e.g. endotoxin and glucan) have been
shown to play a role in the pathogenesis of pulmonary disease (Pirie et al. 2001, 2002b,c).
Heaves is considered to be the result of a respiratory hypersensitivity reaction to inhaled
moulds or occasionally to pollens in the environment (McPherson et al. 1979; Derksen
et al. 1985; McGorum et al. 1993a). Signs of heaves arise from airway obstruction caused
by bronchospasm and plugging of airway lumen with mucous and cellular exudates
(Robinson 2001).
2.1.2. Clinical and bronchoalveolar lavage findings
Clinical signs can be highly variable and mildly affected animals may be asymptomatic
during clinical remission, especially when kept in a high-quality environment (Beech
1991). Of horses performing poorly in a race, 58.3% had no clinical signs of respiratory
disease but were established to have a respiratory disorder upon closer examination (Dixon
et al. 1995). Horses in an asymptomatic stage of the disease but suspected of being heaves
cases can often be diagnosed via a natural hay challenge. Diagnosis of heaves is defined
as a chronic (>2 months) neutrophilic pulmonary inflammation associated with the
presence of hay/straw in the affected horse’s environment and characterized by neutrophilia
(>5%) in BALF (Derksen et al. 1985; McGorum et al. 1993a). Antigen inhalation challenge
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studies can be of help when diagnosing the disease (McPherson et al. 1979). BAL has been
introduced for the use in the horse in the 80´s by Viel (1983) and since then cytological
changes in BALF of healthy and heaves horses have been intensively studied (Whitwell
and Greet 1984; Derksen et al. 1985; Naylor et al. 1992; Tremblay et al. 1993; McGorum
et al. 1993a). Other possible techniques for diagnosis of heaves include transtracheal
aspirates described at 70´s (Mansman and Knight 1972) and endoscopic tracheobronchial
wash (Greet 1982). Diagnosis is, however, usually based on clinical examination and
response to therapy (McPherson and Thomson 1983). The first symptom noticed in horses
by the owner is typically cough when dust levels are high, e.g. during feeding or cleaning
of the stables. At the same time, the owner may observe decreased exercise tolerance. As
the disease advances, prolonged recovery from exercise, nasal discharge, increased respiratory
rate, abdominal breathing and nasal flare occur (McPherson and Thomson 1983; Robinson
2001).
2.1.3. Environmental control of equine heaves
Environmental management is the most effective treatment of heaves (Thomson and
McPherson 1984). Most horses do best when kept outside. Feeding the horse good-quality
food is important. Some horses may require the complete elimination of hay from the
diet. Soaking the hay will also help some horses. Silage (fermented hay) may be another
option. Shredded paper or rubber floor mats can be used as bedding instead of straw or
shavings (Beech 1991; Raymond et al. 1997; Tanner et al. 1998). If horses have to be
stabled, attention should be paid to ventilation. Improved natural ventilation has been
shown to be associated with corresponding improvements in the air hygiene of stables and
in the clinical assessments of horses (Clarke et al. 1987). Good stable design and management
practices can also reduce mould contamination of the air (Clarke 1993; Woods et al.
1993). Separate areas should be allocated to feed production and storage (Kamphues
1996), and heaves horses’ boxes should be situated near the end of a building and not near
the feed or bedding storage, or near damp, humid areas (Clarke 1993; Woods et al. 1993).
2.2 Enzootic pneumonia in calves
2.2.1. General aspects of enzootic pneumonia in calves
Enzootic pneumonia of young calves is an important disease globally. The disease can
occur in both dairy and beef calves. Enzootic pneumonia is defined as an infectious disease
complex affecting primarily housed calves and characterized clinically by bronchointerstitial
pneumonia, which may vary from being subclinical to acute, with or without secondary
bacterial bronchopneumonia. Enzootic pneumonia is multifactorial and is caused by a
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variety of primary pathogens, including respiratory viruses and Mycoplasma sp., attacking
calves with increased susceptibility as a result of failure in immune response. Bacterial
infections are usually secondary to viral infections (Radostits et al. 1994a). Respiratory
diseases are the most important diseases of calves aged 6-8 weeks (Roy 1980). Calf-rearing
units may offer good opportunities for spread of respiratory pathogens, as calves from
different farms are in close proximity while being stressed from transportation (Filion et
al. 1984; Allen et al. 1991). In addition to infectious agents, the environment plays a
prominent role in animals becoming clinically ill; in poor conditions, the disease is more
severe (Radostits et al. 1994a). Pneumonia has been shown to markedly reduce the growth
of calves (Virtala et al. 1996).
Many tools have been used to determine pathogens responsible for respiratory infection
in calves. Bronchopulmonary lavage or tracheobronchial lavage of a standing calf without
sedation has been described (Fogarty et al. 1983; Kimman et al. 1986; Bengtsson et al.
1998; Härtel et al. 2004). BAL has also been conducted in sedated calves in lateral
recumbency (Lakritz et al. 2004) and in sternal recumbency (Pringle et al. 1988). Usually
lavage is done blind using either a self-made catheter or a catheter designed for another
purpose. Also fiberoscopic endoscope has been used for BAL in calves (Pringle et al. 1988;
Allen et al. 1991). The amount of fluid used for sampling of calves has been reported to
vary from 30 ml to 250 ml depending on the method employed and the lavage fluid has
often been phosphate buffered saline (PBS) (Pringle et al. 1988; Bengtsson et al. 1998;
Härtel et al. 2004; Lakritz et al. 2004).
Beef-producing units in Finland have increased in size during the past few years. In larger
units, maintenance of health and resistance to pathogens are more important. Poor air
quality can expose animals to infectious diseases by causing damage to airways. Proper
ventilation reduces the amount of pathogens in respiratory air and minimizes the levels
of dust and other respiratory tract-irritating agents.
2.2.2. Viral agents in enzootic pneumonia
Viruses are considered primary pathogens of enzootic pneumonia in calves. These viruses
include bovine viral diarrhoea (BVD) virus, parainfluenza-3 (PI-3) virus, bovine respiratory
syncytial virus (BRSV), adenoviruses, reoviruses and enteroviruses (Radostits et al. 1994a,b)
and bovine rhinotracheitis virus (Ackermann and Brogden 2000). BVD virus is an important
respiratory pathogen globally (Radostits et al. 1994a) but is very rare in Finland (Härtel
et al. 2004). Bovine herpesvirus 1 (BHV-1, bovine rhinotracheitis) is used commonly in
the studies of artificial enzootic pneumonia (Yates et al. 1983a,b; Jericho and Carter 1984;
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Jericho 1989; Narita et al. 2000), but it has not been detected in Finland thus far (Härtel
et al. 2004).
2.2.3. Respiratory mycoplasmas in enzootic pneumonia
Mycoplasmas are the smallest and simplest prokaryotic cells capable of self-replication.
They do not have rigid cell walls, thus being plastic and highly pleomorphic. Mycoplasmas
stain poorly with Gram-stains (Gram-negative). They range in size from 0.2 to 0.3 μm.
Many mycoplasmas are commensals in the upper digestive, respiratory and genital tracts.
They are reported to be capable of infecting several species, including cattle, swine, sheep,
goats, horses, rats, mice, guinea pigs, dogs, cats and avian species (Carter and Chengappa
1995a). The role of Mycoplasma sp. in the pathogenesis of respiratory disease remains
somewhat unclear, but mycoplasmas may be an initiating factor in enzootic pneumonia,
which is later complicated with pathogenic bacteria (Buchvarova and Vesselinova 1989).
M. bovis is frequently isolated from the respiratory tracts of both healthy and diseased
cattle (Allen et al. 1991), but it apparently does not occur in Finland (Härtel et al. 2004).
Due to the absence of a cell wall, mycoplasmas are fragile, which must be considered when
taking samples. On the other hand, this makes them susceptible to disinfectants and heat,
and they can be destroyed easily from the environment. Furthermore, not having a cell
wall renders mycoplasmas difficult for an animal’s immune system to recognize; generally,
no effective immediate response or long-term immunity can be seen. Some of the clinical
signs with infection result because the mycoplasma confuses the host’s immune system
into reacting against itself. The reservoir for mycoplasmas is carrier animals with chronic,
inapparent infections (Carter and Chengappa 1995a; Wustenberg et al. 2005).
2.2.4. Bacteria in enzootic pneumonia
Secondary bacterial pneumonia is a common occurrence in enzootic pneumonia, often
seen in the most advanced cases. Pathogens include Pasteurella sp., Histophilus somnus
(previously called Haemophilus somnus) and Archanobacter pyogenes (previously Actinomyces
pyogenes) (Radostits et al. 1994a,b). Pasteurella and Mannheimia infections have been
observed to have a synergistic effect with viral infections (Yates et al. 1983a; Jericho and
Carter 1984; Jericho 1989; Narita et al. 2000). Mannheimia infection only a few days
after contracting a viral disease (BHV-1) is considered most severe, but a viral infection
can have an effect on respiratory tract resistance for as long as one month (Yates et al.
1983b). In a study by Filion et al. (1984), stress caused by transportation did not render
calves susceptible to M. haemolytica; however, stressed calves were more susceptible to
BHV-1.
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2.2.4.1. Mannheimia haemolytica
The main pathogen in calf pneumonia is Mannheimia haemolytica (formerly Pasteurella
haemolytica). This is a Gram-negative, non-motile, facultatively anaerobic short coccobacillus
that is catalase- and oxidase-positive and produces acid but no gas during fermentation
of various carbohydrates (Bisping and Amtsberg 1988; Quinn et al. 1994). It can colonize
the upper respiratory tract of healthy animals, and in some animals may cause severe
pneumonia or even death (Allen et al. 1991; Ackermann and Brogden 2000). The severity
of the disease correlates with the dose of M. haemolytica bacteria inhaled (Yates et al.
1983a). M. haemolytica can also infect horses, pigs, sheep and poultry, usually targeting
those with lowered resistance (Bisping and Amtsberg 1988).
2.2.4.2. Pasteurella multocida
P. multocida is also a Gram-negative, non-motile, facultatively anaerobic, short ovoid rod
that is oxidase- and catalase-positive and does not produce gases during fermentation. P.
multocida does not cause haemolysis, which differentiates it from M. haemolytica. In
addition, P. multocida is indole-positive, while M. haemolytica is indole-negative. P.
multocida is divided into the subspecies multocida, septica and gallicia (Bisping and
Amtsberg 1988; Holt et al. 1994; Quinn et al. 1994). P. multocida is the most prevalent
organism (along with Mycoplasma bovis) in nasopharyngeal swabs and BAL samples of
calves with clinical, naturally occurring respiratory disease (Allen et al. 1991). In addition
to being part of the enzootic pneumonia complex in calves, P. multocida can cause lung
infection as a primary pathogen (Jericho and Carter 1984). P. multocida can also cause
respiratory disease in adult cattle, pigs, poultry, sheep, rabbits and dogs (Bisping and
Amtsberg1988). Interestingly, Pasteurella sp. has been demonstrated to be the second most
common pathogen in equine bacterial lower respiratory tract inflammation (Wood et al.
1993).
2.2.5. Inflammation in calf pneumonia
In bovine Mannheimia (Pasteurella) infection, several cell types are involved in the
inflammation process, including endothelial cells of blood vessels, alveolar macrophages,
intravascular macrophages and alveolar epithelial cells. Pro-inflammatory mediators (e.g.
interleukins, tumour necrosis factor-α (TNF-α), prostaglandins, histamine, leukotriene)
are released into the lung in response to Mannheimia virulence factors such as endotoxin
and leucotoxin. M. haemolytica endotoxin clearly has a prominent role in initiating the
inflammatory response in ruminants (Ackermann and Brogden 2000). Accumulation of
neutrophils is typical of acute Mannheimia infection in calves (Slocombe et al. 1985; Weiss
et al. 1991; Narita et al. 2000). Neutrophils secrete a variety of enzymes involved in cell
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migration (Campbell et al. 1987), but in general the targets of their proteolytic enzymes
are relatively non-specific (Weiss 1989; Palmgren et al. 1992). The role of neutrophils in
development of lesions in airway disease was first elucidated by Slocombe et al. (1985),
who found that neutrophil depletion protected calves from experimental M. haemolytica
infection. Later the depletion of neutrophils was demonstrated to markedly attenuate the
size of lung lesions, histopathologic changes and alterations in BALF in M. haemolytica-
infected calves (Weiss et al. 1991). Neutrophils were concluded to mediate the increase
in vascular permeability associated with pneumonic pasteurellosis, and neutrophil depletion
prevented damage to the respiratory tract epithelium (Weiss et al. 1991).
2.3 Organic dust
Inhaled air contains various levels of components that irritate and induce allergy in the
respiratory tract. Organic dust comprises mostly particulate material derived from animals,
plants and micro-organisms (Rylander and Jacobs 1994). Glucan and endotoxin, components
of organic dust, have a role in the pathogenesis of pulmonary disease in horses (Pirie et
al. 2001, 2002b,c) and humans (Thorn 1999). Endotoxin or glucan could be a useful
adjunctive tool to measure the capacity of air to irritate airways. Exposure to moulds, for
instance, can decrease the resistance of airways to environmental microbes and pollutants
(Sjöstrand and Rylander 1997). Providing a healthy environment will improve both animal
and human welfare in animal housing.
Organic dust contains many micro-organisms, including Gram-negative bacteria (Erwinia
herbicola also called Pantoea agglomerans or Enterobacter agglomerans), thermophilic
actinomycetes (Saccharoplyspora rectivirgula and Thermoactinomyces vulgaris) and the
imperfect fungi (Aspergillus sp. and Penicillium sp.) (Milanowski and Dutkiewicz 1990;
Dutkiewicz 1994). The main pathogenic products of these three groups, respectively, are
endotoxin, proteases and glucans (Milanowski et al. 1995). In addition, pollens release
proteolytic enzymes that can contribute to airway epithelial injury (Widmer et al. 2000).
In Finland, animal welfare legislation recommends that organic dust levels do not exceed
10 mg/m3 in animal shelters. The respirable fraction of a microbial aerosol has been shown
to range from 40% to 65% of the total count (Dutkiewicz 1994). Pirie et al. (2002a,b,c)
tested a standardized method for investigation of equine heaves and used hay dust suspension
(HDS) containing both soluble and particulate components for horses to inhale. The
HDS consisted mostly of mould spores of 2-4 μm in diameter (Pirie et al. 2002a). Inhaled
HDS was demonstrated to increase neutrophil numbers in BALF of heaves-susceptible
horses (Pirie et al. 2002b).
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2.3.1. Bacteria
Gram-positive bacteria (mostly Corynebacterium and Arthrobacter) have been shown to
prevail in dust of animal houses (Dutkiewicz 1994). In addition, Gram-negative bacteria,
such as E. herbicola, can be found in organic dust. Gram-negative bacteria in the air are
more harmful for respiratory health because of their endotoxin content.
2.3.1.1. Endotoxin
Endotoxin is a molecule present in the cell wall of Gram-negative bacteria. The term
lipopolysaccharide (LPS) is often used as a synonym for endotoxin, but LPS actually
denotes chemically pure substances. LPS is not a single molecule but is instead a group
of molecules (Jacobs et al. 1997). Endotoxin in animal shelters originates from Gram-
negative bacteria and their fragments that aerosolize from plants (straw, hay and grain)
and animal faeces (Jacobs 1997). Stable dust contains relatively high levels of endotoxin
(up to 60.53 μg/m3) (McGorum et al. 1998). Dutkiewicz (1994) reported endotoxin
concentrations of 0.006-3.4 μg/m3 in horse stables, 0.001-0.013 μg/m3 in cattle sheds
and 1.9-75 μg/m3 in piggeries. Pernis and coworkers recognized the role of endotoxin in
human occupational respiratory diseases in 1961. Since then, numerous studies have been
presented on the role of endotoxins in the pathogenesis of pulmonary disease. Exposure
to endotoxin and its purified derivative LPS is used widely to investigate airway irritation
and inflammation in experimental animals (D’Ortho et al. 1994; Fogelmark et al. 1994;
Ferry et al. 1997; Betsuyaku et al. 1999; Corbel et al. 2001a; Kang et al. 2001; Moreland
et al. 2001; Vernooy et al. 2002) and in humans (Jagielo et al. 1996; Michel et al. 1997;
Kline et al. 1999; O’Grady et al. 2001). Endotoxin has also frequently been used in in
vitro models to stimulate cultured cells to produce pro-inflammatory mediators (Yao et
al. 1997; Palmberg et al. 1998; Aldonyte et al. 2003).
Various cells are able to respond to endotoxins by enhanced mediator production,
phagocytosis, proliferation or differentiation (Ulmer 1997). Endotoxin inhalation has
been shown to increase neutrophil numbers in respiratory secretion of humans (Jagielo
et al. 1996; Michel et al. 1997; Thorn and Rylander 1998a; O’Grady et al. 2001), laboratory
animals (D’Ortho et al. 1994) and horses (Pirie et al. 2001). Furthermore, the numbers
of monocytes in human induced sputum (Michel et al. 1997) and macrophages and
lymphocytes in human BALF (O’Grady et al. 2001) increase following endotoxin inhalation.
Inhalation of LPS has been demonstrated to be dose-dependent in humans, as assessed
by clinical symptoms, lung function tests and neutrophil and cytokine levels in respiratory
secretions (Jagielo et al. 1996; Michel et al. 1997; Palmberg et al. 1998; Kline et al. 1999).
The no-response threshold for acute inhalation of LPS is as low as 0.05 μg. An inhalation
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dose of 50 μg LPS produces both a systemic (e.g. elevated body temperature, blood
polymorphonuclear leucocytes (PMNs), blood and urine C-reactive protein (CRP) and
a bronchial (e.g. increased sputum PMNs, monocytes, lymphocytes) inflammatory response
(Michel et al. 1997). An inhaled dose of 60 μg of endotoxin has been shown to increase
neutrophil counts in induced sputum of normal and asthmatic humans as compared with
placebo (Nightingale et al. 1998). Respiratory symptoms, decline in airflow and inflammation
in the lower respiratory tract are more pronounced when healthy subjects are exposed to
a higher dose of inhaled LPS (6 μg/ml) than to a lower dose (0.9 μg/ml) (Jagielo et al.
1996). Kline et al. (1999) demonstrated a dose response in spirometry results after LPS
inhalation and also showed that reproducibility of the dose response was good. In horses
a dose-dependent neutrophilic airway inflammatory response also occurs with inhalation
of endotoxin (Pirie et al. 2001).
Inhaled endotoxin induces a series of intracellular functional changes in macrophages
(activation). This results in the accelerated production of chemotactic factors, which in
turn leads to neutrophil invasion. Beyond exerting effects on the exposure site itself,
endotoxins may affect the central nervous system. This was shown in findings of such
general symptoms as fatigue, headache and heaviness of the head (Thorn and Rylander
1998a). The role of chronic endotoxin exposure in airway inflammation has been studied
by exposing mice to grain dust for eight weeks (George et al. 2001). Exposed animals
developed persistent airway hyperreactivity and airway remodelling. The cells in lung
lavage samples were almost entirely neutrophils. Inflammation and subepithelial remodelling
(deposition of type III collagen) occurred only in endotoxin-sensitive mice, suggesting the
importance of neutrophils and subepithelial inflammatory response in the development
of chronic airway disease (George et al. 2001). In another chronic exposure study (Corbel
et al. 2001a), mice were exposed repeatedly to LPS and an increase in BALF MMP activity
was seen for MMP-2 and MMP-9. Endotoxin has also been shown to potentiate symptoms
of experimentally induced porcine respiratory corona virus infection in pigs, which normally
results in only mild or subclinical disease (van Reeth et al. 2000).
2.3.2. Fungi
Fungi are eukaryotic, filamentous and mostly spore-bearing organisms that exist as
saprophytes and parasites in animals and plants. More than 80 genera of the major fungal
groups have been associated with symptoms of respiratory tract allergy. However, only a
few species, such as A. fumigatus, Alternaria alternata and Cladosporium herbarum, have
been investigated systematically for their role in causing allergy in people (Kurup et al.
2000). Such fungal species as Micropolyspora faeni (now Faenia rectivirgula), A. fumigatus,
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A. alternata, Penicillium notatum and Thermoactinomyces vulgaris have been implicated
in aetiopathogenesis of heaves (Derksen et al. 1988; Woods et al. 1993, Eder et al. 2000).
Fungi constitute 5-15% of the total micro-organism count in organic dust (Dutkiewicz
1994). Components of fungi having an effect on pathogenesis of respiratory diseases
include antigens present in the spores and fragments of hyphae (Milanowski et al. 1995)
and toxic components of fungal cell walls (Rylander 2001).
2.3.2.1. Glucan
(1    3)-β-D-glucans are a group of fungal, plant and bacterial cell wall components with
immunomodulating effects. Glucan from mould cell walls is a major toxic component of
organic dust (Rylander 2001), and its content in the air reflects mould contamination.
Glucan can directly irritate airways or it can trigger asthma in humans (Rylander et al.
1998). Glucan has been shown to have synergistic effects on airway inflammation together
with endotoxin (Fogelmark et al. 1994; Young et al. 2002). In field studies, a relationship
has been found between exposure to glucan and symptoms of airway inflammation in
humans (Rylander 1997a). Nasal and ocular symptoms and cough have been observed to
be associated in a dose-dependent manner with exposure to fungal spores in farmers
(Eduard et al. 2001). The effect of glucan on development of airway symptoms has been
widely studied from the perspective of human occupational health (Castellan et al. 1984)
and indoor air quality (Rylander 1996).
The role of glucan in the inflammatory process has been demonstrated in a study where
intratracheal challenge with glucan-rich mould cell isolates (Pneumocystis carinii) caused
an elevation in TNF-α and neutrophil counts in lung lavage fluid of mice. The response
was shown to be mostly mediated by the glucan component of the cell wall (Vasallo et
al. 2000). Inhaled glucan also enhances infiltration of eosinophils into the airways of
laboratory mice (Wan et al. 1999).
2.3.2.2. Aspergillus fumigatus
Aspergillus species are saprophytic fungi widely distributed in nature and occurring
worldwide (Kurup et al. 2000). Exposure of heaves horses to mouldy hay induces airway
inflammation, reflected in an elevated number of neutrophils in BALF (Tesarowski et al.
1996). Similarly, inhalation of fungal antigens, such as those from A. fumigatus, has been
shown to cause neutrophilic airway inflammation (Milanowski 1998). Sensitization to
moulds has been found to be a powerful risk factor for severe asthma in adult humans
(Zureik et al. 2002). In addition to allergic sensitization, A. fumigatus can directly infect
the airways; this disease, known as aspergillosis, has received increasingly more attention
>
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as the number of immunosuppressed humans has grown (Latgé 1999). Pulmonary
aspergillosis has also been reported in animals (Jericho and Carter 1984). A. fumigatus
produces serine-type proteases, which have been shown in mice to be capable of hydrolysing
the major structural proteinous barriers in the lung, thus being regarded as an important
virulence factor of this pathogen (Iadrola et al. 1998).
Intranasal exposure of Aspergillus fumigatus extract (AFE) containing both mycelial and
culture filtrate antigens, has been demonstrated to result in accumulation of inflammatory
cells in the airways and airway hyper-responsiveness in mice (Kurup et al. 2001). Milanowski
et al. (1995) reported glucan from yeast and endotoxin from Gram-negative bacteria to
be the most potent stimulants of human alveolar macrophage and neutrophil chemotaxis
in vitro. Endotoxin showed mainly direct chemotactic activity, whereas AFE and yeast
glucan had more indirect effects.
2.3.3. Other dust components
2.3.3.1. Mites
The house dust mite Dermatophagoides pteronyssinus has long been recognized as a major
source of inhaled allergens in humans (Voorhorst et al. 1964, 1967; Tovey et al. 1981).
Many of the house dust mite allergens have hydrolytic activities, including cysteine
proteinase-, serine proteinase- and amylase-like activities. Cysteine proteinase-like activity,
in particular, is suspected of contributing to the tissue pathology seen in asthmatic airways
by increasing epithelial permeability (Robinson et al. 1997; Wan et al. 2000). Serine
proteinase-like activities also have a role in epithelial barrier loss (Winton et al. 1998a,b).
In addition, house dust mite proteolytic allergens can inactivate natural proteinase inhibitors
in airways, such as mammalian serine proteinase inhibitor α1-antitrypsin (Kalsheker et
al. 1996), and stimulate the release of pro-inflammatory cytokines from the bronchial
epithelium (King et al. 1998).
A role for dust mites in allergic respiratory diseases of horses has previously been suggested
by Hockenjos et al. (1981), but this has not been extensively studied. Mainly intradermal
testing has been conducted. The problem with intradermal tests is the high level of false-
positive results. The association between positive results and respiratory symptoms is also
somewhat unclear (McPherson et al. 1979; Hockenjos et al. 1981). IgE antibodies against
different storage mite allergens have been demonstrated by ELISA from sera of both control
horses and horses with chronic bronchiolitis (COPD, heaves) (Eder et al. 2000). Elevated
levels of storage mite (Lepidoglyphus destructor) allergens have been demonstrated in the
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air in a horse management system with hay feed and straw bedding compared to a system
with wood shaving bedding and pelleted diet (Woods et al. 1993). Storage mites are present
in hay and straw and can be seen microscopically in collected hay dust (Pirie et al. 2002a).
Dust mites are dependent on fungal spores, such as A. fumigatus, for food and may decrease
the number of fungal spores and replace them in the form of semi-digested spores in their
faecal pellets. Spores remain, however, antigenic in mite faeces. The mites may disappear
from hay during storage, leaving only faecal pellets and the occasional exoskeleton. A hay
sample with large numbers of mites or their faecal pellets is considered to be of poor quality
(Clarke and Madelin 1987). In addition to house dust mites, the role of storage mites has
also been recognised in the pathogenesis of human asthma and rhinitis as reviewed by van
Hage-Hamsten and Johansson (1998).
2.4 Indicators of airway inflammation
The diagnosis of airway disease, including allergic forms, requires methods or procedures
to differentiate between healthy and diseased subjects. Clinical examination alone cannot,
however, unequivocally identify airway disease. Parameters used to differentiate healthy
subjects from those suffering from allergic airway inflammation include cytology (Dixon
et al. 1995), biochemical indicators of inflammation such as interleukins, cytokines and
acute-phase proteins, clinical scores and neutrophil counts (Gordon 1992; Fogelmark et
al. 1994; Jagielo et al. 1996; Michel et al. 1997; Sjöstrand and Rylander 1997; Palmberg
et al. 1998; Jolie et al. 1999; Kline et al. 1999; Eduard et al. 2001; Pirie et al. 2001,
2002b,c; Young et al. 2002). Irritation of various allergens and toxins in the airways has
been measured from samples of BALF (Kang et al. 2001; Pirie et al. 2001), tracheal
epithelial lining fluid (TELF) (Raulo et al. 2001a) and induced sputum (Michel et al.
1997) of animals and humans. Inhaled endotoxin has also been shown to cause systemic
response in the form of elevated body temperature and increases in blood PMNs and
blood and urine CRPs in humans (Michel et al. 1997). Systemic signs of respiratory
infection in calves include elevated body temperature and increased respiratory rate (Reeve-
Johnson 2001).
Proteolytic activity in airway secretions has previously been measured from heaves horses
(Grüning et al. 1985; Sandholm et al. 1990; Koivunen et al. 1996).  The enzymes
responsible for proteolytic activity have been studied and include lysozymal enzymes
(Sandholm et al. 1990), gelatinases (Raulo et al. 2001a), metalloelastases (Raulo et al.
2000) and collagenases (Raulo et al. 2001b). Proteolytic activity from respiratory secretions
can be measured using direct functional tests (e.g. zymography), immunological tests (e.g.
Western blot) (Sorsa et al. 1994) and inhibition tests with specific inhibitors.
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2.5 Matrix metalloproteinases (MMPs)
2.5.1. Structure and function of MMPs
MMPs are a large group of structurally related but genetically distinct extracellular and
cell surface-associated proteolytic enzymes capable of degrading almost all interstitial and
basement membrane proteins. MMPs are active at neutral pH, are zinc/cation-dependent
and can be inhibited by chelating agents. They are secreted in latent form and activated
in the pericellular or extracellular environment after a small peptide is cleaved from their
N-terminus. MMP catalytic domains are essentially spherical, with a deep substrate cleft
that contains the active-site zinc atom (Birkedal-Hansen 1995). MMPs are divided into
the following subgroups: collagenases, gelatinases, stromelysins, membrane-type MMPs
and other MMPs (Sorsa et al. 2004).
Extracellular matrix (ECM) support to the alveolar structure is essential for normal lung
function. This is achieved by a dynamic balance, in which MMPs actively participate,
between synthesis and degradation of ECM components (O´Connor and FitzGerald
1994). Human neutrophil-derived MMPs have been shown to directly degrade alveolar
ECM. The role of the gelatinases was initially thought to be digestion of gelatin peptides
released from fibrillar collagens by collagenases (Sorsa et al. 2004). Gelatinases have since
been demonstrated to degrade other collagen types (I and II) (Konttinen et al. 1998), in
addition to native type IV collagen (Murphy et al. 1985), the major constituent of the
basement membrane, which supports the airway epithelium (O´Connor and FitzGerald
1994). This has led to the suggestion that the major role of gelatinases is the digestion of
basement membrane during inflammatory cell migration (O´Connor and FitzGerald
1994; Vermaelen et al. 2003).
2.5.2. Regulation of MMPs
2.5.2.1. Activation
MMPs are often secreted in latent form and usually activated after a small 10-kDa peptide
is cleaved from their N-termini. MMPs can thus be recognized in both inactive and active
forms based on molecular weight. Activation of MMP occurs in the extracellular space
or at the cellular surface and is controlled by other proteases such as trypsin (Sorsa et al.
1997; Duncan et al. 1998), membrane-anchored MMP (Johnson 2001) or other MMPs.
Stromelysin (MMP-3), for instance, is known to activate MMP-9 (Inuzuka et al. 2000;
Rosenberg et al. 2001). Natural activators of MMPs also include neutrophil serine proteases,
which can induce various cells, such as epithelial cells, to upregulate MMP-9 expression,
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and are often associated with MMP-9 activation (Palmgren et al. 1992; Watanabe et al.
1993). MMP-9 activation has been reported in in vitro models following exposure to free
radicals or reactive oxygen species (ROS) (Weiss 1989; Paquette et al. 2003). ROS can
be released from alveolar macrophages and from neutrophils along with proteases during
the inflammation process (Shah et al. 1987; Piotrowski and Marczak 2000). Oxidant
production and ROS may also increase expression and activation of MMPs (Yoshida et
al. 2001). Activation of MMP-9 by ROS has been described in experimental bacterial
meningitis of rats (Meli et al. 2003). Alveolar macrophages, epithelial cells and neutrophils
produce increased amounts of ROS in response to air pollution particles (Tao et al. 2003).
LPS (Yao et al. 1997; Aldonyte et al. 2003), TNF-α and IL-1β (Yao et al. 1997) have also
been shown to induce RNA upregulation and subsequent MMP protein expression, often
associated with secondary activation of MMPs. In addition, bacterial proteases have been
demonstrated to activate host MMPs (Sorsa et al. 1992). Of the synthetic activators, 4-
aminophenyl mercuric acetate (APMA) is an optimal organomercurial activator of both
MMP-2 and MMP-9 (Sorsa et al. 1997; Kähäri and Saarialho-Kere 1999).
2.5.2.2. Inhibition
Tissue inhibitors of MMPs (TIMPs) are 20- to 30-kDa proteins that bind to the catalytic
domain of MMPs in 1:1 stoichiometry, thereby inhibiting the enzymatic activity of MMP
(Johnson 2001). TIMPs inhibit the activity of various MMPs with different affinities. An
imbalance between TIMPs and active MMPs leads to excessive tissue destruction at the
sites of inflammation (Ingman et al. 1996; Sorsa et al. 2004). There are four members of
the TIMP family. TIMP-1 and -2 are secreted in soluble form and bind with high affinity
to active MMP. In addition, TIMP-1 can form a complex with the zymogen of MMP-9,
and TIMP-2 with MMP-2 (Corbel et al. 2000). TIMP-1 has been reported to be significantly
higher in the sputum of asthmatics and patients suffering from chronic bronchiolitis than
in healthy subjects (Vignola et al. 1998). TIMP-2 can reduce cellular infiltrates in BALF
and tracheal walls, likely due to the inhibition of the movement of leucocytes from the
circulation to the site of inflammation. TIMP-2, TIMP-1 and synthetic MMP inhibitor
all reduce development of allergic airway inflammation, possibly by inhibiting MMP-2
and MMP-9 (Kumagai et al. 1999).
Since MMPs are dependent on cations and zinc, chelating agents such as EDTA can be
used for inhibition. Moreover, several other synthetic inhibitors, which may be specific
to certain MMPs, are available. Many pharmacological compounds can inhibit MMPs,
as reviewed by Beckett et al. (1996). Interestingly, corticosteroids, which have long been
used as one of the main treatments for equine heaves, have been shown to reduce MMP-
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2 and MMP-9 levels and inhibit neutrophil infiltration in mice with acute LPS-induced
lung injury (Corbel et al. 1999). In vivo dexamethasone treatment has also been demonstrated
to decrease MMP-9 release by 80% in BAL alveolar macrophages of both healthy and
asthmatic humans (Mautino et al. 1997). Another inhibitor, tetracycline, has been
extensively used to treat calf pasteurellosis because of its antibiotic effect. In human
periodontal disease, an MMP inhibitory effect of doxicycline has been demonstrated in
vitro and in vivo, with the doxicycline-treated group having a substantially improved
clinical condition compared with the placebo group (Golub et al. 1997, 1998; Emingil
et al. 2004a,b). Chemically modified tetracyclines from which the antibiotic effect has
been removed have also been developed (Golub et al. 1998). Chemically modified
tetracycline-3, for instance, prevented endotoxin-induced lung injury in a pig model of
human acute respiratory distress syndrome by apparently inhibiting both MMP-2 and
MMP-9 (Carney et al. 2001).
2.5.3. Gelatinases MMP-2 (gelatinase A) and MMP-9 (gelatinase B)
Gelatinases (MMP-2 and MMP-9) are a subgroup of MMPs with the capacity to digest
components of the basement membrane (Birkedal-Hansen et al. 1993). Human MMP-
2 and MMP-9 have been demonstrated to be able to degrade several substrates, including
type IV collagen, elastin (Senior et al. 1991) and native type I and II collagens, similarly
but clearly slower than interstitial collagenases (Konttinen et al. 1998). As gelatinolytic
MMPs are pro-inflammatory agents, they may contribute to destruction of the airways,
leading to diminished lung function. In a murine model of asthma, allergen inhalation
increased both MMP-9 and MMP-2 levels (Kumagai et al. 1999). MMP-2 and MMP-9
have been shown to play a role in the pathogenesis of Escherichia coli mastitis in dairy
cows by degrading the blood-milk barrier in the early phase of disease, thus promoting
invasion of the blood-derived cellular components into milk (Raulo et al. 2002). In
addition, in experimental fungal keratitis in rabbits, both MMP-2 and MMP-9 are elevated,
and the activity does not originate from fungi (Gopinathan et al. 2001). MMP-2 and
MMP-9 participate in remodelling of lung tissue after injury caused by sodium hydroxide
(Legrand et al. 1999) or hyperoxia (Buckley et al. 2001) in vitro. MMP-2 is produced by
most cell types of the alveolar wall (Bakowska and Adamson 1998) and pleural surfaces
(Hurewitz et al. 1992), including fibroblasts, endothelial cells and alveolar epithelial cells
(Corbel et al. 2000). MMP-9 is produced mainly by inflammatory cells, such as
polymorphonuclear neutrophils, monocytes, macrophages, eosinophils and lymphocytes,
but also under certain conditions by cells that synthesize MMP-2, such as endothelial or
alveolar epithelial cells (Corbel et al. 2000) and alveolar macrophages (Finlay et al. 1997a).
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MMP-9 has been identified in bovine (Li et al. 1999), porcine (Girard et al. 2001) and
human (Sepper et al. 1994; Finlay et al. 1997b) neutrophils as well as in human mast cells
(Kanbe et al. 1999), canine macrophages and epithelial cells (Rajamäki et al. 2002) and
equine BALF neutrophils, macrophages and lymphocytes (Raulo et al. 2001). In addition,
gelatinolytic MMP activity has been reported in pig polymorphonuclear leucocytes (Murphy
et al. 1989).
2.5.4. MMP-2 and MMP-9 in airway diseases
In inflammation of airways, cells, especially white blood cells (WBCs), secrete MMP-9
into tissues. One of the main functions of this enzyme is to enable migration of WBCs
to the site of inflammation (Watanabe et al. 1993). Kumagai and colleagues (1999)
demonstrated upregulated release of both MMP-2 and MMP-9 in association with
inflammatory cells to airways after allergen challenge in mice, and prevention of cellular
infiltration and induction of airway hyperresponsiveness following inhibition of MMPs.
Because a broad spectrum MMP inhibitor was used, the specific contributions of MMP-
9 or MMP-2 could not be assessed. The balance between secretion of MMPs and their
inhibition may be disturbed in inflammation, leading to excessive destruction of the ECM.
MMPs are known to play a role in the pathogenesis of various airway diseases, including
allergic-type diseases of both humans and animals. Gelatinolytic MMPs have previously
been reported in association with human emphysema (Finlay et al. 1997b), equine heaves
(Raulo et al. 2001a) and canine pulmonary eosinophilia (Rajamäki et al. 2002), as well
as in various experimentally induced airway diseases such as PRRSV (Girard et al. 2001)
and mycobacterium infection of laboratory mice (Quiding-Järbink et al. 2001).
Elevated levels of gelatinolytic MMPs have been described in endotoxin-induced airway
diseases of horses (Nevalainen et al. 2002), guinea-pigs (D’Ortho et al. 1994), hamsters
(Ferry et al. 1997), mice (Corbel et al. 2001a) and humans (Michel et al. 1997). LPS
stimulation has been used in in vitro studies to induce MMP production, and it has been
shown to elevate both MMP-2 (D’Ortho et al. 1997) and MMP-9 (Yao et al. 1998)
expression. MMP levels have also been reported to increase after chronic exposure to LPS
in a murine model (Corbel et al. 2001b). Total gelatinolytic activity as well as MMP-9
and MMP-2 levels are elevated in BALF from rats challenged with LPS intratracheally
(Kang et al. 2001). In human volunteers, local installation of LPS into lungs led to a
marked elevation of MMP-9 in BALF (O’Grady et al. 2001). LPS-stimulated human
macrophages from subjects with COPD secreted significantly greater basal MMP-9 levels
and significantly lower IL-8 levels than healthy controls (Aldonyte et al. 2003).
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MMP-9 is typically elevated in chronic, allergic-type lung diseases, including equine
COPD (Raulo et al. 2001a) and human asthma (Mautino et al. 1997; Ohno et al. 1997;
Prikk et al. 2002). MMP-9 is also a good marker of inflammation and tissue destruction
in equine heaves (Raulo et al. 2001a); it is in fact the main pathologically elevated MMP
in bronchoalveolar and tracheobronchial secretions from heaves horses. Immunoreactivity
of MMP-9 has been shown to be elevated in respiratory secretions of heaves horses
compared with controls (Raulo et al. 2001a). Healthy horses generally express low levels
of proMMP-9. Nevalainen et al. (2002) demonstrated that exposure of healthy and heaves-
affected horses to inhaled hay/straw dust, HDS or LPS resulted in increased amounts of
inflammatory cells and MMP-9 in heaves horses. Exposure to endotoxin caused an elevation
in MMP-9 levels in healthy controls as well. However, total levels of MMP-9 were higher
and more activated in heaves horses than in healthy controls. Absolute BALF neutrophil
counts were highly correlated with levels of proMMP-9 and active MMP-9 (Nevalainen
et al. 2002).
When the role of MMP-9 in airway inflammation was studied using transgenic MMP-9
-/- mice, dendritic cells (leucocytes) were found not to be able to infiltrate airway mucosa
and not to reach the airway lumen in sufficient numbers during allergen-induced airway
inflammation without MMP-9 (Vermaelen et al. 2003). The authors concluded that the
absence of MMP-9 activity inhibited the development of allergic airway inflammation by
impairing the recruitment of dendritic cells to the airways and the local production of
dendritic cell-derived proallergic chemocines (Vermaelen et al. 2003). Another study using
MMP-9 deficient mice reported contribution of MMP-9 to the development of pulmonary
inflammation and airway hyperreactivity (McMillan et al. 2004). Allergen challenge to
the airways of sensitized MMP-9-deficient mice resulted in heightened airway inflammation
in comparison with wild-type mice, suggesting that MMP-9 plays a role in recruiting
leucocytes to inflammatory sites through the lung. Also the duration of inflammation was
longer in MMP-9 knockout mice than in wild-type controls, indicating that MMP-9
might be important in the resolution of lung injury after allergen challenge (McMillan
et al. 2004).
Expression of MMP-2 in airways seems to be more constitutive than MMP-9. MMP-2
has been shown to be only slightly elevated in BALF from heaves horses compared with
healthy controls (Raulo et al. 2001a), and the same can also be seen in mice following
allergen challenge (Kumagai et al. 1999; Corry et al. 2002). MMP-2 (and MMP-9) levels
are elevated in pigs suffering from PRRSV infection (Girard et al. 2001). Elevated levels
of MMP-2 have been detected in BALF from human patients suffering from bronchiectasis,
a lung disease in which lung tissue is destroyed by repeated respiratory infections (Sepper
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et al. 1994). Mycobacterium bovis and M. tuberculosis have been observed to induce MMP-
2 and MMP-9 expression in alveolar macrophages in vitro as well as in vivo in several
tissues of immunocompetent mice, thus indicating a role for MMPs in development of
tubercles (Quiding-Järbrink et al. 2001).
The role of MMP-2 in airway inflammation has also been studied by using transgenic
MMP-2 -/- mice (Corry et al. 2002). The absence of active MMP-2 resulted in excessive
accumulation of inflammatory cells in lung parenchyma when mice were challenged with
allergen. The authors concluded that the principal function of MMP-2 is to facilitate
egression of allergenic inflammatory cells into the airway lumen (Corry et al. 2002). It
remains, however, unclear how the production of protease by fibroblasts within the stromal
component enhances migration of leucocytes across the epithelium and into the airway
lumen (Sheppard 2002).
2.5.5. Proteolytic activity of environmental origin
There has been debate on the source of proteolysis; does it originate from the host itself
or from bacteria, fungi, pollutants, mites or combinations of these. Inhaled proteinases
may induce respiratory epithelial damage and inflammatory cell recruitment. Serine
proteinases from A. fumigatus can degrade the pulmonary epithelium (Iadrola et al. 1998),
and storage mites produce a similar proteinase profile (Stewart and Thompson 1997). A.
fumigatus is known to express both serine- and metalloproteinase propeptides, which are
selective inhibitors of their respective mature enzymes (Markaryan et al. 1996). The house
dust mite produces serine- and cysteine-type proteolytic allergens capable of degrading
the epithelial lining of airways (King et al. 1998; Winton et al. 1998a,b; John et al. 2000;
Wan et al. 2000). Bacterial proteinases from culture extracts of Pseudomonas aeruginosa
have been shown to express gelatinolytic activity in vitro, but these contribute little to
gelatinolytic activity, as measured from sputum supernatants of patients with cystic fibrosis
(Delacourt et al. 1995).
Despite the many similarities with mammalian and microbial metalloproteinases, there
are also differences in gelatinolytic activity expresion. Bacterial metalloproteinases are
secreted in latent form, like eukaryotic proteinases; e.g. the Vibrio vulnificus 45-kDa
metalloproteinase is generated from the 66-kDa precursor (Miyoshi and Shinoda 2000).
Miyoshi et al. (1998) showed V. vulnificus metalloproteinase to be capable of degrading
type IV collagen. This proteinase is classified as a thermolysin, a 35-kDa protein, belonging
to to a subgroup of bacterial metalloproteinases. Gelatinolytic enzymes tend to be slightly
different in substrate specificity and molecular weight than eukaryotic types, but bacterial
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metalloproteinases can also activate host-originating metalloproteinases (Sorsa et al. 1992;
Maeda and Yamamoto 1996; Miyajima et al. 2001). Bacterial proteinases on the cell
surfaces of microbes can also activate host proMMPs (Ding et al. 1997).
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3. AIMS OF THE STUDY
This work had the following two objectives: a) to evaluate the effect of dust and its
components on equine airways and b) to investigate the effect of microbial infection on
the calf respiratory tract. The main variables measured were the levels and degree of
activation of MMP-2 and MMP-9 in respiratory secretions. Specific aims were as follows:
1. To examine the effect of inhaled dose of HDS, LPS and AFE on BALF
gelatinolytic MMP-2 and MMP-9 levels and activation in healthy and heaves-
susceptible horses.
2. To study the effect of Aspergillus fumigatus and AFE-LPS on BALF gelatinolytic
MMP-2 and MMP-9 levels and their activation in heaves-susceptible horses.
3. To assess the effect of HDS containing different amounts of glucan on BALF
gelatinolytic MMP-2 and MMP-9 levels and their activation in healthy and
heaves-susceptible horses.
4. To evaluate the effect of soluble and particulate fractions of HDS on BALF
gelatinolytic MMP-2 and MMP-9 levels and their activation in healthy and
heaves-susceptible horses.
5. To develop an in vitro method to detect differences in direct MMP-9 activation
capacity of various allergens.
6. To study gelatinolytic MMPs in microbial airway infection using TBLF from
calves with concurrent Pasteurella and mycoplasma sp. infection.
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4. MATERIALS AND METHODS
4.1. Animals
4.1.1. Horses (I, II)
Subjects comprised seven horses (three geldings, four mares; median age 17 years, range 8-
28 years; median weight 434 kg, range 323-594 kg) with a history and clinical diagnosis of
heaves and six healthy control horses (all female; median age 6 years, range 4-9 years; median
weight 320 kg, range 316-356 kg). Horses were from the research horse stock of the University
of Edinburgh, Scotland, UK (Pirie et al. 2001, 2002a,b,c, 2003a,b) (Table 1).
Table 1. Inhalation challenges of heaves-susceptible (heaves) and control horses (controls)
included in Studies I and II. Challenges included diluent control (saline), hay dust
suspension (HDS), endotoxin (LPS), washed particles of HDS (WP), supernatant of
HDS (SUP), Aspergillus fumigatus extract (AFE) and various combinations of these.
Controls Heaves
Challenge 1 2 3 4 5 6 7 8 9 10 11 12 13
saline + + + + + + + + + + + + +
HDS-1 100 mg + + + - + + + + + + + + +
HDS-2 100 mg ND ND ND ND ND ND + + + + + + -
HDS-3 100 mg ND ND ND ND ND ND + + + + + + +
20 μg LPS + + + + + + + + + + + + +
200 μg LPS + + + + + + + + + + + + +
2000 μg LPS + + +  - + + + + + + + + +
HDS-1 31 mg ND ND ND ND ND ND + + + + + + +
HDS-1 57 mg + + + - + + + + + + + + +
HDS-1 100 mg + + + - + + + + + + + + +
HDS-1 316 mg + - + - + + ND ND ND ND ND ND ND
WP ND ND ND ND ND ND + + + + + + +
SUP + + + - + + + + - + + - +
WP+SUP ND ND ND ND ND ND + + + + + + +
HDS-LPS + + + - + + + + - + + + +
HDS-LPS+LPS ND ND ND ND ND ND + + + + + + +
WP+LPS + + + - + + + + + + + + -
AFE 0.5 mg ND ND ND ND ND ND + + + + + + +
AFE 1.6 mg ND ND ND ND ND ND + + + + + + +
AFE 5.0 mg ND ND ND ND ND ND + + + + + + +
AFE-LPS ND ND ND ND ND ND + + + + + + +
ND, not done; - no readable result from zymography, + included in analyses
4.1.2. Calves (IV)
Eleven calves with clinical symptoms of respiratory disease and positive TBLF cultures for
Pasteurella and mycoplasma sp. from five different farms in Finland and six healthy controls
with no clinical signs of respiratory disease and negative TBLF cultures were used. The
sex and breed of the diseased calves was not recorded, the controls were all female ayrshire
breed calves. Six of the diseased calves were from farms rearing dairy-bred bull calves for
beef production, two from dairy farms and three from farms with mixed dairy and beef
production. Control calves were from two Finnish dairy farms. The median age of the
diseased calves was 103 days (range 54-206 days) and of the control calves 67 days (range
58-101 days). The eleven diseased calves were selected from altogether 90 calves lavaged
for another study and for clinical diagnosis (Härtel et al. 2004).
4.2. Inhalation challenge substances
4.2.1. Hay dust suspension (HDS) -1,-2 and -3 (I, II, III)
HDS was produced from visibly mouldy batches of hay by Dr. Pirie. The hay was agitated
manually, and visible plant debris was removed. Dust was sieved two times, collected and
suspended in sterile saline, and this suspension was then filtered. HDS was stored frozen
at -80°C (Pirie et al. 2002a).
In Study I, HDS-1 (57, 100 and 316 mg for control horses and 31, 57 and 100 mg for
heaves horses) was used in inhalation challenges. In Study II, three different HDSs were
used. HDS-1 and HDS-3 had similar amounts of LPS, but their glucan contents differed
significantly (Table 2). These two compounds had different effects on BALF neutrophil
counts and lung resistance in a previous study (Pirie et al. 2002b), and the aim in Study
II was to determine whether differences existed in MMP levels between challenges with
these three HDSs. Higher glucan content likely reflected a higher spore concentration,
but it may also reflect different fungal species (Rylander 1997a). Analysis of glucan content
of HDS-2 was not performed, but its endotoxin concentration resembles that of HDS-1
(Table 2). In the paper by Pirie et al. (2002b), where neutrophil data following challenges
with different HDSs were reported, HDS-1, HDS-2 and HDS-3 were also used. In Study
II, MMP data following challenges with HDS-1 and HDS-2 are presented. The coding
between the data presented here and that by Pirie et al. (2002b) differs in that HDS-2
in Pirie et al. (2002b) is named HDS-3 here, and HDS-3 in Pirie et al. (2002b) is HDS-
2 here and in Study II. MMP data following HDS-3 (HDS-2 in Pirie et al. 2002b) are
only reported here, not in the original articles.
‒ 38 ‒
‒ 39 ‒
Table 2. Endotoxin and glucan concentrations of hay dust suspensions (HDS) -1, -2
and -3.
HDS-1 HDS-2  HDS-3
Endotoxin concentration (μg/ml) 21.6 15.2  18.2
Glucan concentration (μg/ml) 184 596 ND
ND, not determined
4.2.2. Aspergillus fumigatus extract (AFE), AFE depleted of endotoxin
(AFE-LPS) and AFE with resumed endotoxin (AFE+LPS) (I)
AFE 0.5, 1.6 and 5 mg in addition to one dose of mould extract (AFE 1.6 mg) depleted
of endotoxin (AFE-LPS) were administered to horses by inhalation. Inhalation protocols
and endotoxin depletion are described by Pirie et al. (2003a). Endotoxin content of AFE
was reduced by 69% (from 2.1 μg/ml to 0.66 μg/ml) when AFE-LPS was produced.
Production of AFE is further described in Section 4.4.1. Endotoxin (LPS) added to AFE
(resulting in AFE-LPS+LPS) following depletion was from the Salmonella typhimurium
Ra60 strain (kindly provided by Professor Ian Poxton, University of Edinburgh). AFE-
LPS and AFE-LPS+LPS were prepared Dr. Pirie.
4.2.3. Endotoxin (LPS) (I, II)
Inhalation challenges include three different dose levels of LPS (20, 200 and 2000 μg).
The LPS was purified from the S. typhimurium cell wall (Pirie et al. 2001).
4.2.4. Soluble (SUP, WF) and particulate (WP) fractions of HDS (I, II)
The components of HDS were separated by centrifugation to yield a supernatant (SUP)
reflecting the endotoxin concentration of HDS, and a particulate component reflecting
the glucan content of HDS. The particles were repeatedly washed to yield a washed
particulate (WP) fraction comprising mainly fungal spores to represent the glucan content
of HDS, and a wash fluid (WF) fraction comprising saline and soluble components washed
from the surface of the particulates (Pirie et al. 2002c).
4.3. Inhalation challenges and sample collection in horses (I, II)
Sterile saline was used as a diluent control for each challenge. Challenges undergone by
each horse are presented in Table 1. The procedure for bronchoalveolar lavage fluid (BALF)
collection 6 h after each of these challenges is reported elsewhere (Pirie et al. 2001, 2002b,c).
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BALF was processed as previously described (Raulo 2001) and stored in aliquots at -80˚C
prior to collecting samples for MMP analysis. All the challenges and BALs were conducted
by Dr. Pirie.
4.4. In vitro samples (III)
4.4.1. Aspergillus fumigatus extract (AFE)
A. fumigatus extracts, AFE1 and AFE2, were culture filtrate (from the external dialysis
phase liquor) and somatic (from the disrupted mycelium inside the dialysis tube), respectively.
A. fumigatus antigen extracts were produced by the double dialysis method of Edwards
(1972), originally developed for Micropolyspora faeni to produce antigenic material for
serological testing of farmers’ lung disease. Application of the method for A. fumigatus
and the strain used are described elsewhere (Edwards et al. 1990).
4.4.2. Mite extract (MITE)
Mite extract was produced from mites/mite faeces by Dr. Pirie. The mites were found on
the underside of large round bales of hay. The mite species was not identified, but they
were apparently storage mites living in hay that had fallen out of the bale at some point
during storage. One hundred milligrams of these mites/mite faeces were mixed with 1 ml
of saline and then filtered through nylon gauze.
4.4.3. Hay dust suspension (HDS) and its soluble (SUP, WF) and particulate
(WP) fractions
Hay dust suspension (HDS) and its components, originally developed to provide a means
for investigating equine heaves and standardizing the diagnosis, were given as an aerosol
to horses. Preparation of HDS and its fractionation are described in Sections 4.2.1 and
4.2.4 and by Pirie et al. (2002a,c). HDS is reported to possess proteolytic activities
representing both serine and metalloproteinases. General proteolytic activity was studied
with a commercial kit, in which casein acted as a proteolytic substrate. The role of
metalloproteinases was reflected by EDTA inhibition, and that of serine proteinases by
aprotinin inhibition. HDS-1 has been shown to have proteolytic activities corresponding
to a 28-kDa serine protease and 85-kDa and 160-kDa metalloproteinases (Pirie et al.
2002a). SUP has been reported to contain most of the original HDS proteinase activity
(Pirie et al. 2002c).
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4.5. In vitro study design (III)
A dilution series was prepared in saline for each component to determine the highest
concentration not causing gelatinolytic activity in gelatin zymography, which could disturb
interpretation of the results. The concentrations selected for activation of commercially
purchased human recombinant proMMP-9 (Calbiochem, San Diego, CA, USA) were:
AFE1 and AFE2 concentrations 0.5 mg/ml, MITE 1 mg/ml and HDS 0.1 mg/ml.
Dilutions for fractions were WF 1:10, WP 1:10 and SUP 1:100; their production from
HDS is described elsewhere (Pirie et al. 2002c).
Appropriate dilutions were made in TNC buffer. Aliquots of 18 μl of each dilution were
placed in Eppendorf tubes, and 2 μl of proMMP-9 dilution (1:50) was added. Controls
comprised 2 μl of pure enzyme in 18 μl of TNC buffer and 2 μl of enzyme in 16 μl of
TNC supplemented with 2 μl of APMA. A series of five parallel samples of each allergen
was incubated for 2 h at 37ºC. Following incubation, 10 μl of the original volume of
samples was collected for Western immunoblot, and the remainder was used for gelatin
zymography. Enzyme activity was stopped by freezing the samples (zymography) or by
adding sample buffer and heating (Western immunoblot).
4.6. Clinical examination and sample collection in calves (IV)
4.6.1. Clinical examination
Calves were selected for the control and diseased groups based on clinical examination
and bacterial and mycoplasma cultures of TBLF. In clinical examination, special attention
was paid to respiratory disease symptoms, including cough and nasal or ocular discharge.
Mucous membranes, the navel and the joints were palpated, and body temperature was
measured. The heart and lungs were auscultated, and heart and respiratory rates were
recorded, as were any abnormal heart or lung sounds. If any of the above-mentioned
investigations revealed symptoms of disease, the calf was not accepted into the control
group. When a calf had clinical symptoms of respiratory disease, abnormal respiratory
sounds on auscultation and positive bacterial cultures for Pasteurella and Mycoplasma sp.
it was taken into the diseased calves’ group.
4.6.2. Tracheobronchial lavage
Tracheobronchial lavage was performed as described by Bengtsson et al. (1998). An assistant
restrained the animal and stretched the neck. A sterile plastic tube was passed through one
of the nostrils via the ventral nasal meatus into the trachea. A smaller tube was passed
through the outer tube as far as possible. Next, 30 ml of sterile phosphate-buffered saline
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(PBS) was passed through the tube and immediately withdrawn using the same syringe.
The lavage was repeated with an additional 20 ml if enough sample was not withdrawn.
The amount and the appearance of lavage fluid drawn back were not recorded for the
diseased calves. For controls, the amount varied from 2 ml to 4.5 ml, and appearance from
slightly cloudy to grey, with blood occasionally present. After collecting part of the sample
for the bacterial culture media and the mycoplasma culture media for diseased calves, the
rest of the sample was stored frozen to await further studies.
4.6.3. Blood samples
Blood samples were obtained by venopuncture from the vena jugularis into tubes containing
EDTA and no additive. Total and differential WBC counts, red blood cell counts and
haemoglobin and fibrinogen levels were analysed.
4.7. Bacterial and mycoplasma analyses of calf samples (IV)
4.7.1. Bacterial cultures and API20NE test
TBLF was cultured for aerobic and anaerobic bacteria (Härtel et al. 2004). In addition,
fresh samples from diseased calves were cultured for mycoplasma. Control calves’ TBLF
was cultured for mycoplasma after it had been stored frozen. Bacterial cultures were
prepared at the National Veterinary and Food Research Institute, after which the strains
were frozen. In the control group, there was no growth in bacterial cultures, while in the
diseased group growth of Pasteurella sp. occurred. Five of the 11 bacterial isolates were
identified with API20NE (BioMérieux, France) as being P. multocida, and six of the
isolates could not be identified with API20NE. Oxidase reaction was tested for interpretation
of API20NE results using BBL Dry Slide Oxidase tests (Becton Dickinson and Company,
Sparks, MD, USA).
4.7.2. Mycoplasma cultures and polymerase chain reaction
All of the samples from the 11 diseased calves had positive Mycoplasma sp. cultures. In
addition eight diseased calves had growth of Mycoplasma dispar in their TBLF. Mycoplasma
cultures were prepared from fresh samples at the Faculty of Veterinary Medicine, Department
of Microbiology, for diseased calves, and from frozen samples at the National Veterinary
and Food Research Institute for the control group. The samples were further studied with
PCR at the National Veterinary and Food Research Institute to identify M. bovis and M.
bovirhinis (Johansson et al. 1996; Kobyashi et al. 1998). None of the calves had M. bovis
in PCR, but six of 11 diseased calves and two of six healthy controls had a positive M.
bovirhinis PCR finding.
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4.7.3. Bacterial suspension
To test the suitability of McFarland standard in quantification of bacteria, Pasteurella sp.
from one diseased calf sample was suspended from blood agar culture to PBS to yield
approximately 109 bacteria/ml (McFarland standard 5) (Fig. 1). The McFarland standard
estimated the number of Pasteurella colony-forming units (CFU) in a suspension well.
It was used for making bacterial suspensions of all recovered strains in a sterile saline to
ensure the same number of bacteria in each sample. The loss of bacterial cell wall integrity
was demonstrated by culturing bacterial dilution series from two of the suspensions.
Figure 1. Schematic presentation of the preparation of bacterial suspensions for gelatin
zymography. PBS, photoshate-buffered saline; CFU, colony-forming unit.
4.8. Assays
4.8.1. Gelatin zymography (I-IV)
Gelatin zymography was performed essentially as described by Raulo et al. (2001) to
determine the levels and degree of activation of MMP-9 (I-IV) and MMP-2 (I, II and
IV). The bands in the zymogram were identified by molecular weight as complex forms
(>110 kDa), proMMP-9 (90-110 kDa), active MMP-9 (75-85 kDa), proMMP-2 (65-
75 kDa) and active MMP-2 (<65 kDa) (Raulo et al. 2001a). MMP levels were measured
densitometrically using a computer program (Cream, Kem-En-Tek, Copenhagen, Denmark)
and expressed as area under integration of curve of height times intensity of band in the
zymogram. The term active refers to 75- to 85-kDa MMP-9 and <65-kDa MMP-2.
Activation was calculated as the percentage of active MMP-9 of both active MMP-9 and
proMMP-9, activation percentage for MMP-2 was calculated similarly. Total gelatinolytic
activity refers to the sum of levels of complex forms, proMMP-9, active MMP-9, proMMP-
2 and active MMP-2 detected in zymography.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with gels
containing 1 mg/ml gelatin (Type A: porcine skin, Sigma, G-2625) as a substrate were
used. Before electrophoresis, the samples were incubated at a ratio of 2:1 with sample
buffer containing 25 m of 0.471 M Tris (Sigma, T-1378) 0.256 M H3PO4 (Merck, Art.
573), pH 6.8, in 100 ml of dH2O with 20% glycerol (Merck, Art. 4094), 0.04%
bromophenol blue (Merck, Art. 8122) and 6% SDS (BDH Chemicals Ltd., prod. 44244)
for 2 h at room temperature. Electrophoresis was run for 2 h at 4°C with a constant current
of 20 mA. After electrophoresis, the gels were washed in 50 mM Tris-HCl (Sigma), 2.5%
polysorbate 80 (Tween 80, Merck, P-1754) and 0.02% (w/v) NaN3 (Riedel de Haën AG,
13412), at a pH of 7.5 for 30 min, then the same buffer supplemented with 100 μM
ZnCl2 (Merck, Art. 8816) and with 5 mM CaCl2 (Merck, Art. 12382-1) for 30 min.
The final incubation was performed in 50 mM Tris-HCl, 5 mM CaCl2, 100 μM ZnCl2
and 0.02% NaN3, pH 7.5, at 37°C for 24 h. The reaction was interrupted by staining
the gels with 1.2 mM Coomassie brilliant blue R250 (Serva, 35051) and destaining. A
molecular weight standard (Low Range, Bio Rad, Hercules, CA, USA) containing stained
phosphorylase B (106 kDa), bovine serum albumin (77 kDa), ovalbumin (50.8 kDa),
carbon anhydrase (35.6 kDa), soybean trypsin inhibitor (28.1 kDa) and lysozyme (20.9
kDa) was used.
4.8.1.1. EDTA inhibition (IV)
Inhibition with EDTA was performed similarly to TBLF samples, except for adding 10
mM EDTA (Merck, Art. 8418) to the preincubation buffer and a 1-h preincubation at
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37°C. Furthermore, 10 mM EDTA was added to the washing buffers and to the incubation
buffer (Raulo et al. 2001a).
4.8.2. Western immunoblot (III)
Western immunoblot was used to identify MMP-9. Specific rabbit polyclonal anti-human
MMP-9 antibodies were used. Polyclonal anti-human MMP-9 has previously been used
to detect various and distinct multiple molecular weight forms/species of human and rat
MMPs (Sorsa et al. 1994; Westerlund et al. 1996; Hanemaajier et al. 1997; Pirilä et al.
2002). The corresponding specificity of the antibodies and their ability to detect equine
MMPs have been tested earlier (Raulo et al. 2001a; Nevalainen et al. 2002). Gelatinolytic
bands detected by zymography were immunologically identified by Western blot. Samples
were separated by using gel electrophoresis on 7-10% SDS polyacrylamide gels and
transferred to nitro-cellulose membranes. Western blots were not carried out under reducing
conditions. Non-specific binding was blocked with 5% non-fat dry milk in 10 mM Tris-
HCl, pH 7.5, containing 22 mM NaCl and 0.05% Triton-X (TTBS) for 1 h. The
membranes were then incubated with antibodies against MMP-9 (1:500 dilution) for 12
h at 22°C, followed by peroxidase-conjugated goat anti-rabbit antibodies (1:1000 dilution)
for 1 h at 22°C. The membranes were washed 4-6 times for 15 min in TTBS between
each step. The proteins were visualized using the enhanced chemiluminescence (ECL)
system (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
4.8.3. Scanning of gels
Gelatinolytic activity was visualized as clear bands against a blue background (I-IV). Results
were quantified by placing the gels on a scanner (Scanjet 4C/T, Hewlet Packard, Espoo,
Finland) connected to an image analysis and processing system (Cream, Kem-En-Tek,
Copenhagen, Denmark). Densitometric results were calculated in area mode after converting
the pictures to grayscale and subtracting the background grey values. The results were
expressed as area under the curve of height of the band times the brightness of the band.
A standard sample (mixture of equine BALF) was run on each gel and used as a positive
control. All of the samples evaluated were run at the same time using four gels, which
were handled similarly and simultaneously by the same person (T. Simonen-Jokinen).
Standardization between gels was achieved by adhering to the same incubation times
throughout the study and by comparing values for standard samples. By using the molecular
weight standard, the bands in the zymogram were identified as complex forms, proMMP-
9, active MMP-9, proMMP-2 and active MMP-2 according to molecular weights and
results from previous studies (Raulo et al. 2001a). Gelatinolytic bands >110 kDa were
designated as complex forms, bands 90-110 kDa as proMMP-9, bands 75-85 kDa as
active MMP-9, bands 65-75 kDa as proMMP-2 and bands <65 kDa as active MMP-2.
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In Western immunoblot, specific MMP-9 immunoreactivity was visualized as dark bands
against a clear background (III). Standardization of Western immunoblot was achieved
by using a molecular weight standard, similar incubation times and antibody dilutions,
simultaneous handling of the gels. In addition, all samples evaluated were run on the same
gel, and all analyses were performed by the same person (T. Tervahartiala). The membranes
were recorded by a scanner linked to an image analysis and processing system. The back-
ground grey level of the membrane was subtracted, and the densitometric results were
calculated in area mode (Mellanen et al. 1998; Raulo et al. 2001a).
4.9. Statistical methods
Data were analysed with SPSS for Windows (SPSS Inc., Chicago, IL, USA) (I-IV) and
Minitab 13 (Minitab Inc., PA, USA) (II). Significance was assumed at p<0.05.
In Study I, the non-parametric Mann-Whitney U-test was used to analyse differences
between control and heaves horses. Paired-samples t-test was used to compare differences
of each challenge with saline challenges of individual horses. In Study II, all but HDS of
the compared samples were included in the same run. Differences between control and
heaves horses were analysed using non-parametric Mann-Whitney U-test. The data for
healthy controls were evaluated using randomized block variance analysis. Differences
between challenges of heaves horses were initially analysed using the Kruskall-Wallis test
for non-parametric, non-paired data. When a significant difference was detected between
challenges, individual challenges were compared using the Mann-Whitney U-test for non-
parametric, non-paired data. Since the mean of total gelatinolytic activity for saline
challenges was identical among different gels, statistical comparisons of results between
gels were performed. In Study III, differences between allergens and controls were analysed
by randomized block variance analysis, and in Study IV, statistical analyses were made
using t-test for independent samples.
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5. RESULTS
5.1. Gelatinolytic MMPs in equine challenges (I, II)
Gelatin zymography revealed the most prominent zones of lysis at 92 kDa and 82 kDa.
Similar bands from partly same samples were previously identified as proMMP-9 and
active MMP-9 by Western immunoblot using polyclonal antibodies (Nevalainen et al.
2002). These gelatinolytic proteases are most likely MMP-9 based upon Western immunoblot
analysis, molecular weights and inhibition by EDTA. Other gelatinolytic bands were seen
at 72 kDa and 68 kDa. Complex forms (molecular weight >110 kDa) of gelatinases were
also observed.
5.1.1. Endotoxin, HDS and AFE dose responses (I)
MMP-2 levels did not show clear dose-dependency in Study I. The lowest dose (20 μg)
endotoxin (LPS) challenge did not significantly elevate total gelatinolytic activity, proMMP-
9 or active MMP-9 levels in heaves horses or controls compared with saline challenge.
The LPS inhalation challenge of 200 μg failed to elevate any of the MMPs studied in
controls. Following LPS challenge of 200 μg and 2000 μg, total gelatinolytic activity, total
MMP-9 and proMMP-9 levels were all significantly elevated in heaves horses compared
with saline challenges (p<0.01 for all) or the 20-μg challenge (p<0.05 for all). In controls,
total gelatinolytic activity, total MMP-9 and proMMP-9 levels were elevated following
LPS challenge of 2000 μg compared with saline (p<0.05 for all) or LPS challenge of 20
μg (p<0.05 for all). In addition, complex forms were elevated in heaves horses following
LPS inhalation challenge of 2000 μg compared with saline (p<0.05). No significant
differences between controls and heaves-susceptible horses were seen.
In controls, only the challenge with the highest HDS inhalation dose, 316 mg, resulted
in a significant MMP elevation, as reflected in the levels of total MMP-9 and active MMP-
9 compared with HDS challenge of 31 mg (p<0.05 for both). Total gelatinolytic activity
(p<0.05 and p<0.05), total MMP-9 (p<0.0.01 and p<0.05) and proMMP-9 (p<0.01 and
p<0.05) levels were elevated in heaves horses following their highest challenge dose, 100
mg, compared with saline challenge and challenge of 31 mg. Total gelatinolytic activity
and total MMP-9 levels were significantly elevated in heaves-susceptible horses compared
with controls following HDS challenge of 100 mg (p<0.05 for both).
A. fumigatus extract (AFE) challenge with 1.6-mg and 5.0-mg doses clearly increased total
gelatinolytic activity (p<0.05 for both),  total MMP-9 (p<0.01 for both) and proMMP-
9 (p<0.01 for both) levels in BALF from heaves-affected horses as compared with saline
challenge. Levels of active MMP-9 were significantly elevated following challenges with
both 1.6 mg and 5.0 mg compared with saline challenge (p<0.01 for both) or AFE
challenge of 0.5 mg (p<0.05 and p<0.01, respectively). Depletion of LPS from AFE
resulted in a significant decrease in active MMP-9 levels (p<0.05). AFE challenges were
performed only with heaves-susceptible horses.
5.1.2. Response to inhalation challenge with different HDSs (II)
Gelatin zymography of BALF following challenges with HDS-1, HDS-2 and HDS-3 was
performed for heaves horses only (Fig. 2). Results for HDS-1 and HDS-2 are reported
in the original article (II). Following HDS-2 and HDS-3 challenges, total gelatinolytic
activity (p<0.01 for both), complex forms (p<0.01 for both), total MMP-9 (p<0.01 for
both), proMMP-9 (p<0.01 for both) and active MMP-9 (p<0.05 and p<0.01) were all
significantly elevated compared with saline challenge. HDS-2 inhalation challenge resulted
in elevated levels in total gelatinolytic activity and complex forms as compared with HDS-
1 (p<0.05 for both). ProMMP-9 levels were elevated following HDS-1 inhalation challenge
(p<0.05) compared with saline challenge. No significant difference was observed in MMP-
2 levels following these challenges.
Figure 2. Densitometric analysis of zymography gels showing the mean density (±SEM)
of active MMP-2, active MMP-9, proMMP-2 and proMMP-9 BALF of heaves-susceptible
horses. 0: saline, 1: hay dust suspension -1 (HDS-1), 2: HDS-2, 3: HDS-3.
5.1.3. Response to inhalation challenge with soluble (SUP) and particulate
(WP) fractions of HDS (II)
To further explore the effect of the individual dust components glucan and endotoxin,
fractions of HDS (SUP and WP) were inhaled separately. The results for heaves-susceptible
horses are reported in the original article (II). Compared with saline challenge, neither
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inhalation challenge with the WP fraction nor challenge with the SUP fraction alone
significantly increased any MMP studied. In controls, only saline, HDS and SUP challenges
were conducted. Both proMMP-2 (p<0.05) and total MMP-2 (p<0.01) levels in this
group were significantly elevated following inhalation challenge with SUP compared with
levels following HDS challenge.
5.1.4. Combined effect of hay dust fractions (II)
To determine whether both soluble and particulate components are necessary to induce
elevated gelatinolytic activity, combinations of WP+SUP (heaves horses only) and WP+LPS
(heaves horses and controls) were inhaled. Results for heaves-susceptible horses are reported
in the original article (II). In controls, complex forms (p<0.05), proMMP-2 (p<0.05) and
total MMP-2 (p<0.05) levels were elevated following WP+LPS challenge compared with
saline challenge, and total MMP-2 levels also compared with LPS inhalation challenge
(p<0.05). No significant difference was observed between WP+SUP, WP+LPS and HDS
inhalation challenges with respect to any BALF MMP component in heaves-susceptible
horses. Total gelatinolytic activity, proMMP-9 and active MMP-9 levels were significantly
elevated in heaves horses’ BALF compared with controls following WP+LPS challenge
(p<0.05 for all).
5.1.5. Response to depletion of endotoxin from HDS (II)
Results of total gelatinolytic activity, complex form, proMMP-9 and active MMP-9 levels
following challenges with HDS, HDS depleted of endotoxin (HDS-LPS) and HDS with
resumed LPS concentration (HDS-LPS+LPS) are presented in Fig. 3. In control horses,
challenges were conducted only with HDS and HDS-LPS. No significant differences were
found in this group in total gelatinolytic activity, complex forms or MMP-9 or MMP-2
levels.
Figure 3. Densitometric analysis of zymography gels showing the mean density (±SEM)
of total gelatinolytic activity, complex forms, proMMP-9 and active MMP-9 BALF of
heaves-susceptible horses (grey bars) and controls (black bars) following challenges with
hay dust suspension (HDS), HDS depleted of endotoxin (HDS-LPS) and HDS-LPS
with resumed endotoxin corresponding to the amount previously depleted (HDS-
LPS+LPS).
5.2. In vitro activation of proMMP-9 (III)
5.2.1. Gelatinolytic activity of challenge substances
All of the allergens studied possessed proteolytic activity of their own, observed as they
were run in gelatin zymography in a dilution series. The major gelatinolytic activities were
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in WF dilutions of 1:1 and 1:5 at about 25 kDa and below 20 kDa. In MITE, there were
two bands seen in dilutions of 1:1, 1:5, 1:25 and 1:100 at about 40 kDa and below 20
kDa. In WP, a fuzzy band was detected at 25 kDa with dilutions of 1:1 and 1:5. In SUP,
gelatinolytic activity was most evident at 25 kDa and well below 20 kDa in dilutions of
1:1 to 1:100. In HDS dilutions of 1:1 to 1:100, one clear band was observed at below
20 kDa. In AFE-1 and AFE-2 two gelatinolytic bands were seen at 70-120 kDa and two
bands at 30-50 kDa in dilutions of 1:1 and 1:5. For MMP-9 activation, dilutions not
showing proteolytic activity in gelatin zymography were selected. The gelatinolytic activities
seen represented mainly low molecular weight areas and not the same molecular weight
range as for MMP-9; bands at 90-110 kDa were considered proMMP-9, and those at 75-
85 kDa active MMP-9.
5.2.2. Direct MMP-9 activation by hay dust and its components
All allergens (WF, MITE, WP, SUP, AFE-1 and AFE-2), except HDS, significantly (p<0.01)
activated MMP-9 as compared with the negative control buffer. HDS also caused activation
of MMP-9, but the difference was not significant (p=0.085). The positive control (1 mM
APMA) resulted in a higher activation of MMP-9 than WF, WP, SUP, HDS and AFE-2
(p<0.01 for all). The positive control also activated MMP-9 more efficiently than MITE
(p<0.05). No significant difference was present between AFE-1 and the positive control.
AFE-1 activated MMP-9 significantly more than WF (p<0.05), WP (p<0.01), SUP
(p<0.05) or HDS (p<0.01). AFE-2 activated MMP-9 more efficiently than HDS (p<0.05).
MITE resulted in a significantly higher activation of MMP-9 than WP (p<0.05) and HDS
(p<0.01).
5.2.3. Western immunoblot
Gelatinolytic bands seen in zymograms were identified as pro- and active forms of MMP-
9 by Western immunoblot.
5.3. Gelatinolytic activity of tracheobronchial lavage fluid (TBLF) in calf
Pasteurella multocida infection (IV)
5.3.1. Gelatinolytic MMPs in TBLF
Increased levels of gelatinolytic MMPs were seen in both healthy and diseased calves. Total
gelatinolytic activity and complex forms just failed reaching significantly elevated levels
in diseased calves TBLF samples as compared with controls (p=0.053 and p=0.052,
respectively). The levels of proMMP-9 and proMMP-2 did not differ between groups.
Active enzyme forms of MMP-9 (p<0.05) and MMP-2 (p<0.05) were elevated in diseased
calves’ TBLF compared with controls. Relative activation was significantly elevated in the
diseased calves’ group (p<0.05) for MMP-2. No statistical difference was present between
diseased calves and controls in activation percentage of MMP-9 (IV).
Data in the diseased calves’ group were additionally grouped using the API20NE test (not
reported in Study IV) (Table 3). Total gelatinolytic activity (p<0.05), complex form
(p<0.01), proMMP-9 and active MMP-9 (p<0.05 for both) levels were elevated in the P.
multocida API20NE-positive group compared with controls. No difference existed between
these groups in proMMP-2 and active MMP-2 levels. The activation percentage was higher
in P. multocida API20NE-positive diseased calves’ TBLF for both MMP-9 and MMP-2
than in healthy controls, but the difference was significant only for MMP-9 (p<0.05). No
significant differences were found between the P. multocida API20NE-unidentified group
and healthy controls.
Table 3. Results from bacteriological and mycoplasma cultures and PCR of diseased
and control calves’ TBLF.
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ND, not determined
Calf Bacterial Mycoplasma Mycoplasma
cultures API20NE     cultures      PCR
Controls Mycoplasma sp. M. dispar M. bovirhinis M. bovis
1 - ND - - - -
2 - ND - - - -
3 - ND - - - -
4 - ND - - - -
5 - ND - - + -
6 - ND - - + -
Diseased Mycoplasma sp. M. dispar M. bovirhinis M. bovis
7 Pasteurella sp. unidentified + + + -
8 Pasteurella sp. unidentified + + - -
9 Pasteurella sp. P. multocida + + + -
10 Pasteurella sp. P. multocida + - + -
11 Pasteurella sp. P. multocida + - + -
12 Pasteurella sp. P. multocida + - + -
13 Pasteurella sp. P. multocida + + + -
14 Pasteurella sp. unidentified + + - -
15 Pasteurella sp. unidentified + + - -
16 Pasteurella sp. unidentified + + - -
17 Pasteurella sp. unidentified + + - -
Total gelatinolytic activity and complex forms were more elevated in the P. multocida
API20NE-positive group (p<0.05 for both) than in the API20NE-unidentified group,
and the level of active MMP-9 just failed being significantly higher in the P. multocida
API20NE-positive group (p=0.56). A significant difference could, however, be seen in
activation percentage of MMP-9, which was higher in P. multocida API20NE-positive
calves (p<0.05).
Mycoplasma status of healthy controls did not have an effect on gelatinolytic activity in
TBLF. In the diseased calves’ group, a positive PCR finding of M. bovirhinis had an effect
on gelatinolytic activity. Total gelatinolytic activity (p<0.01), complex (p<0.01), proMMP-
9 (p<0.01), active MMP-9 (p<0.01) and total MMP-9 (p<0.01) levels were all elevated
in M. bovirhinis-positive diseased calves compared with M. bovirhinis-negative diseased
calves. In addition, the activation percentage of MMP-9 just missed being significantly
elevated in the M. bovirhinis-positive diseased calves’ group (p=0.056).
5.3.2. Gelatinolytic activity of bacterial suspensions
Bacterial suspensions did not express any measurable gelatinolytic activity reflecting MMP-
2 or MMP-9 according to the methods applied (not reported in Study IV). Some pale
gelatinolytic bands as well as darker bands were seen in the zymogram, but no activity was
apparent in the molecular weight range of MMP-2 or MMP-9.
5.3.3. EDTA inhibition
The use of 10 mM EDTA totally inhibited all gelatinolytic activity in TBLF samples, thus
evidencing the metalloproteinase nature of the enzymes detected in zymography.
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6. DISCUSSION
6.1. Rationale for performing the study and ethical considerations
Heaves horses exposed to airborne organic stable dust and its components serve as excellent
models for examining respiratory inflammation in general because of the large sample
volume that can be obtained by BAL. Previously, elevated levels of MMPs in equine BALF
have been found in natural heaves cases (Raulo et al. 2001a) and in healthy and heaves-
susceptible horses in response to allergen challenges with endotoxin, hay dust and hay/straw
exposure (Nevalainen et al. 2002). Increased levels of BALF MMP-9 have also been
reported in humans following inhalation challenges with allergens, including ragweed, cat
allergen and house dust mite, compared with controls challenged with saline (Kelly et al.
2000). Respiratory challenge studies improve knowledge about the pathogenesis of allergen-
induced respiratory diseases. Dose-dependency studies are needed to determine whether
the parameter used is capable of assessing the severity of disease induced by different levels
of the irritant. In addition, dose-dependency studies aid in establishing acceptable levels
of airway-irritating substances, such as endotoxin, in animal shelter air from the perspectives
of occupational health and animal welfare. Knowledge of the harmfulness of various types
of dust and its components helps to determine which dust / dust components should be
minimized in animal shelters.
To further investigate the effect of inhaled allergens, BALF from heaves-susceptible and
control horses challenged with various allergens was examined for gelatinolytic MMPs.
All of the challenges had been conducted in previous studies (Pirie et al. 2001, 2002a-c,
2003a,b), so there was no need for new animal challenges in Studies I and II. Furthermore,
the role of gelatinolytic MMPs in microbial respiratory infection of calves was investigated.
In Study IV, the samples from diseased calves had been obtained earlier for diagnostic
purposes (Härtel et al. 2004). Samples from control calves (IV) were obtained here and
were collected with the methods approved by Institutional Animal Care and Use Committee
of the University of Helsinki. In Study III, an in vitro method for studying allergen capacity
to activate gelatinolytic MMP-9 was developed. This new method reduces the need for
experimental animals in the future.
6.2. Methods employed
6.2.1. Sampling techniques for obtaining BALF and TBLF
TBLF (IV) is obtained from higher parts of the respiratory tract than BALF (I, II).
However, Raulo et al. (2001a) demonstrated that in horses comparable levels of gelatinolytic
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MMPs were detected in BALF and tracheal epithelial lining fluid (TELF) samples. Thus,
gelatinolytic activity detected in secretions from the upper airways may also be assumed
to correlate with tissue destructive processes in the lower airways. Moreover, the amount
of fluid recovered by TBL from calves (IV) is much smaller than the amount from equine
BAL. This is due to different volumes used for lavage and the size difference between
horses and calves. Furthermore the amount of recovered fluid varies and the tube dead-
space has an effect on sample dilution. Raulo et al. (2001a) did, however, show that MMP
levels from equine tracheal lavage with only 10 ml of fluid were comparable with levels
obtained from BAL with 300 ml of fluid. Dilution of BAL and TBL samples was unknown,
as no tools for accurate determination of the dilution factor exist (Haslam and Baughman
1999). Instead, it has been recommended that a standard inoculation volume, a standard
number of input aliquots and a standard sampling site should be used (Haslam and
Baughman 1999). These instructions were followed in our studies (I, II, IV) when ever
possible. Endogenous and exogenous markers to determine the dilution in BALF have
been employed. In horses, the use of urea and albumin has been studied to determine the
dilution factor. However, urea and albumin tend to overestimate the volume of withdrawn
fluid. Also the time from instillation to aspiration has an effect on concentration of urea
and albumin in BALF (McGorum et al. 1993b).
6.2.2. Sample sizes
Sample size in equine studies (I, II) was determined by samples obtained from previous
studies (Pirie et al. 2001, 2002a-c, 2003a,b). As all BALF samples did not yield readable
gelatin zymography results, the sample size was rather small. In Study III, a series of five
parallel samples for all allergens was analysed. The main criterion for calf allocation into
the diseased or control groups was bacterial and mycoplasma culture results from TBLF
(IV). Clinical scores and respiratory rate have been shown to be predictive of lung
consolidation. However, lung consolidation has not correlated with bacterial isolation,
indicating that other bacterial effects also contribute to clinical signs (Reeve-Johnson
2001). Clinical examination alone is considered insufficient for the selection of normal
calves for pulmonary studies (Pringle et al. 1988). Bacterial flora from TBL and
nasopharyngeal swab samples has been shown to differ little between cases and controls:
In a study of Allen and colleagues (1991) P. multocida was isolated more frequently from
diseased calves than from clinically normal controls and M. haemolytica, in turn, was
isolated more frequently from controls than from cases. M. bovis was frequently isolated
from the respiratory tracts of both clinically healthy and diseased calves (Allen et al. 1991).
Based on these previous findings, the aim was to confirm bacterial infection by culturing
the lavage samples. Many calves had to be lavaged to find 11 diseased calves with both
‒ 55 ‒
clinical signs and positive bacterial culture results (IV). The subject pool was thus rather
small, not allowing any epidemiological conclusions to be drawn.
6.2.3. Timing of samples
In Study III, the incubation time of 2 h was based on a time series done as a preliminary
study (data not shown), what showed peak activation at this time with the in vitro method
used. In horses (I, II), the samples were obtained 6 h post-challenge. In calves (IV),
however, the time of the infection was unknown because they were not experimentally
infected, but represented a naturally infected, more heterogeneous group. This lead to
great variation in MMP levels, depending on the stage of the disease. The timing of sample
collection may have an effect on which MMPs are detected and whether they are detected
in pro- or active forms. In previous studies, airway MMP levels after acute disease have
been examined in controlled trials, where the time of the tissue damage is known (Girard
et al. 2001; Nevalainen et al. 2002). Raulo et al. (2002) showed in an endotoxin mastitis
model that elevated levels of MMP-2 are found only during the first few hours after
endotoxin challenge, and MMP-9 levels rise later. Maisi et al. (2001) reported that sampling
of respiratory fluid must be done during the first 12 h after airway challenge to find
activated forms of MMP-9.
Challenges with HDS and hay/straw markedly increased both active MMP-9 levels and
proMMP-9 levels, with MMP-9 levels being highest as early as 5 h after challenge and
returning to baseline levels in 4 days (Nevalainen et al. 2002). This is very close to the
optimum sampling time (6 h) used in our equine challenges (I, II), indicating that we
succeeded in measuring MMP-9 levels at their highest point. In the study of Girard et
al. (2001), MMP levels in PRRSV-infected pigs were maximal between days 7 and 14
post-infection, and these levels remained elevated for up to 1.5 months. In mycobacterial
infection (M. tuberculosis) of mice, increased MMP-9 levels were detected 1 week post-
infection with MMP-2 increasing after week 2 (Rivera-Marrero et al. 2000). A murine
model of asthma revealed that MMP-9 was elevated at 5 days post-challenge and MMP-
2 at 3 days (Kumagai et al. 1999). Another murine model of acute lung injury showed
that MMP-2 bands were most intense between 3 days and 1 week after lung injury, with
the intensity gradually dropping over a 6-week period, and 92-kDa gelatinase was only
detected during the first week post-injury (Bakowska and Adamson 1998). MMP-2 levels
in horse BALF samples (I, II) showed no clear pattern: in some saline challenges, they
were even greater than in HDS or fraction challenges. This may be due to different time
peaks of MMP-2 and MMP-9 release (Kumagai et al. 1999). MMP-2 is produced by most
cell types of the alveolar wall (Bakowska and Adamson 1998), including fibroblasts,
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epithelial cells and endothelial cells (Corbel et al. 2000), and this local expression may
explain its earlier elevation compared with mainly neutrophil-derived MMP-9. By contrast,
both active MMP-2 and active MMP-9 were elevated in TBLF of diseased calves (IV),
but significant elevation of pro-forms was not present. This may be due to an overly long
incubation time (24 h) in zymography, small sample size or suboptimal sample timing.
6.2.4. Gelatin zymography and Western immunoblot
Gelatinolytic activity was studied by SDS-page gelatin zymography (I-IV). Bands were
identified based on molecular weights (complex forms >110 kDa, proMMP-9 90-110
kDa, active MMP-9 75-85 kDa, proMMP-2 65-75 kDa and active MMP-2 <65 kDa)
and results from earlier studies (Raulo et al. 2001a; Nevalainen et al. 2002), where partly
the same samples (BALF following HDS-1 and 2000-μg LPS challenges) were analysed
and Western immunoblot was applied to identify MMP-9 and MMP-2. Presence of
calcium at neutral pH (I-IV) and inhibition with EDTA (IV) were also used to identify
gelatinolytic bands as MMPs, as was Western immunoblot (III).
6.3. Dose-dependent MMP-9 elevation following LPS challenge
The effects and dose-dependency of endotoxin (LPS) (20, 200 and 2000 μg for heaves-
susceptible horses and controls) on MMP-9 and MMP-2 levels in BALF were investigated
(I). MMP-9 levels in respiratory secretions are increased in a dose-dependent manner after
inhaled LPS challenges. A dose-dependent response of MMPs to any airway irritant has
not been reported in vivo before. Stable dust has been shown to have endotoxin concentrations
exceeding those causing symptoms in humans (McGorum et al. 1998). In healthy humans,
the no-response concentration to inhalation of LPS has been reported to be as low as 0.5
μg, after which changes in blood neutrophils are seen (Michel et al. 1997). Most healthy
humans develop significant airflow obstruction with a LPS dose of 40 μg (Kline et al.
1999). In guinea-pigs, as little as 0.05 μg/m3 of endotoxin in inhaled air caused inflammatory
changes in BALF, indicating that tissue destruction occurs at doses below those causing
clinical symptoms (Gordon 1992). In a Polish study, the endotoxin concentration in horse
stables varied from 0.006 to 3.4 μg/m3, in cattle sheds from 0.001 to 0.013 μg/m3 and
in piggeries from 1.9 to 75 μg/m3 (Dutkiewicz 1994). In human occupational environments,
the recommended cut-off level of endotoxin to avoid increased risk for airway inflammation
in normal or atopic subjects is 0.01 μg/m3 (Rylander 1997b). Reported threshold values
vary considerably, however, depending on whether pure endotoxin or contaminated dusts
are used (Michel 1997). In horses, doses of inhaled LPS of up to 2000 μg did not cause
a significant increase in clinical scores, lung mechanics or arterial blood analysis results.
However, in BALF cytology, differences were present already at a 20-μg LPS challenge
‒ 57 ‒
dose as compared with saline challenge (Pirie et al. 2001). In Study I, elevated gelatinolytic
activity and MMP-9 levels were induced following an LPS challenge of 200 μg. While
BALF supernatant is used for the analysis of gelatinolytic activity and MMP-9 levels, only
secreted MMPs are analysed. This seems to indicate that cellular invasion occurs already
at a dose of 20 μg of LPS, whereas 200 μg of LPS is required to induce secretion of MMP-
9 into the BALF fluid of horses.
6.4. Dose-dependent MMP-9 elevation following HDS challenge
The effect of HDS (57, 100 and 316 mg for controls and 31, 57 and 100 mg for heaves-
susceptible horses) on MMP-9 and MMP-2 levels in BALF was investigated (I). Study I
showed that when challenging airways with different HDS doses gelatinolytic BALF MMP
levels, mainly represented by MMP-9, react dose-dependently. HDS was produced from
mouldy hay and mostly comprised 2- to 4-μm mould spores. Other less abundant
constituents included mite exoskeleton fragments, mite faeces, larger mould spores, plat
debris and unidentifiable debris (Pirie et al. 2002a). When the airways are challenged with
high doses of HDS, the BALF neutrophil ratio increases in both heaves-susceptible and
control horses. The neutrophilic response to HDS is dose-dependent in both groups,
indicating that even healthy horses may develop pulmonary inflammation in response to
extremely dusty stable air (Pirie et al. 2002b).
6.5. Dose-dependent MMP-9 elevation following AFE challenge
The effect of AFE (0.5, 1.6 and 5.0 mg for heaves horses) on MMP-9 and MMP-2 levels
in BALF was investigated (I). The role of A. fumigatus in the development of equine heaves
is interesting and this is the first study in which MMP levels were demonstrated to increase
in BALF in response to mould (AFE) challenge. In Study I, the response of gelatinolytic
MMP levels was not linearly dose-dependent. A plateau was seen between 1.6-mg and
5.0-mg doses in total gelatinolytic activity as well as in complex and total MMP-9 levels.
A similar plateau was seen in neutrophil counts in an earlier study (Pirie et al. 2003a),
where the plateau in neutrophil counts was hypothesized to be some kind of allergen
saturation. Surprisingly, a plateau was not seen with active MMP-9 or with activation
percentage of MMP-9, both of which were dose-dependently elevated. No difference
between saline challenge and LPS-depleted AFE in neutrophil count was detected by Pirie
et al. (2003a). In Study I, however, a difference was present in total gelatinolytic activity
and active MMP-9 levels when AFE-LPS was compared with saline. The response to AFE-
LPS was greater than expected for endotoxin alone (20 μg) in all studied parameters, which
supports the theory of other compounds, in addition to LPS, contributing to development
of heaves (Pirie et al. 2003a).
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A. fumigatus  resulted more elevated levels of active MMP-9 in vivo than LPS or HDS (I),
both of which resulted in more constant levels of active MMP-9. This potent activation
capacity was also seen in vitro (III). Furthermore, A. fumigatus is known to be a potent
activator of cell infiltration and free radical production in lungs (Milanowski 1998). It is
often used as a model to study fungal allergies. A. fumigatus has been shown to have
allergens in common with other fungi (Hemmann et al. 1997; Chow et al. 2000); thus,
it can be assumed that AFE challenge, at least partially, represents general fungal response.
A. fumigatus has been demonstrated to have a greater potency to induce inflammatory
response than endotoxin (Milanowski 1998). Also Eduard et al. (2001) also found a
stronger association between clinical symptoms and fungi than between these symptoms
and endotoxin in farmers’ working environment air, suggesting a more important role of
fungi as compared with endotoxin.
In a previous study of mould extract inhalation in horses (Pirie et al. 2003a), a 5-mg dose
of AFE resulted in a significant increase in eosinophils, not in neutrophils. Interestingly,
the plateau seen in neutrophilic response was not present in MMP-9 levels, which were
dose-dependently elevated (I). Neutrophils and macrophages play a major role in immunity
to A. fumigatus by destroying fungi in the airways in clinical aspergillosis. In allergic airway
disease, the amount of fungal components in the airways is smaller, and the fungi do not
cause mycotic infection. However, the same cells might be responsible for the removal of
antigenic substance in the airways, and thus, the proteolytic enzymes secreted from
macrophages and neutrophils during this process may also have a role in the pathogenesis
of allergic airway disease (Latgé 1999). The response to AFE challenge can be seen at lower
doses in BALF MMP levels than in neutrophil counts (Pirie et al. 2003a), indicating also
the need for use of these supplemental methods with different threshold levels in detecting
inflammation. Neutrophil counts are usually the most sensitive marker of inflammation,
while clinical symptoms are less specific. Analysis of gelatinolytic activity yields further
information, at least for research purposes. The increase in MMP-9 levels seems not to
be specific to any challenge used (i.e. HDS, LPS and AFE), and therefore, MMP-9 levels
could serve as a general biochemical marker of the level of respiratory tract irritation.
6.6. Effect of different HDSs on gelatinolytic MMP levels
The effect of three different HDSs on gelatinolytic MMP-9 and MMP-2 levels in BALF
was analysed (II). HDS-1 and HDS-2 had almost the same amount of LPS but significantly
different glucan contents. These compounds had markedly different effects on BALF
neutrophil counts and lung resistance in a previous study (Pirie et al. 2002b), and our
objective was to determine whether differences exist in MMP levels between challenges
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with these three HDSs. Analysis of glucan content of HDS-3 was not performed, but its
endotoxin concentration resembled that of HDS-1. HDS-1 caused the least elevation in
gelatinolytic activities in BALF as compared with the HDS-2 and HDS-3 challenges. The
latter two resulted in similar patterns in the zymogram, although HDS-3 caused more
elevated levels of active MMP-9 than HDS-2. The glucan concentration of HDS-2 was
approximately three times higher than that of HDS-1 (Pirie et al. 2002a) (note that the
codes here are different from those in Pirie et al. 2002a-c, with the codes for HDS-2 and
HDS-3 being reversed). The fungal component (glucan) of dust was shown to be associated
with more elevated levels of active MMP-9. Higher glucan content likely reflected higher
spore concentration, but it might also reflect different fungal species (Rylander 1997a).
Greater potency of HDS-3 did not appear to be related to proteinase content since HDS-
1 and HDS-3 exhibited similar proteinase activity (Pirie et al. 2002a).
6.7. Effect of soluble and particulate fractions of HDS on gelatinolytic
MMP levels
BALF from challenges with different fractions of HDS was analysed for gelatinolytic
MMPs (II). These fractions comprised supernatant (SUP), representing the soluble part
of HDS and including most of the endotoxin, and particulate matter, which was washed
to yield washed particles (WP) and wash fluid (WF). WP, from fractionating of HDS and
representing the glucan content of HDS, could not alone significantly elevate gelatinolytic
MMPs. SUP, representing the endotoxin concentration of HDS, also failed to cause
significant elevation in BALF MMP levels. When these two were combined (WP+SUP),
an elevation was seen in all parameters studied. However, the difference was significant
only for complex forms compared with saline challenge; for other parameters (total
gelatinolytic activity, proMMP-9, active MMP-9, proMMP-2 and active MMP-2), the
MMP levels did not reach those for the whole HDS challenge. This suggests that there
are some components on the surface of particles that contribute to airway inflammation
but that were washed away when WP was produced. WP and WF (wash fluid from
producing WP from HDS) have been shown to induce a slight airway neutrophilia in
heaves horses, and SUP+WP a neutrophilia similar in magnitude to that following HDS
challenge (Pirie et al. 2002c).
Inhaled glucan has been demonstrated to promote airway eosinophilic infiltration in mice
(Wan et al. 1999). In guinea-pigs, Sjöstrand and Rylander (1997) reported that glucan
alone caused only a minor increase in lung lavage neutrophil counts, which further
emphasizes the synergistic effect of glucan and endotoxin on respiratory tract irritation.
While both glucan and endotoxin are known to be able to irritate the airways separately
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(Rylander et al. 1998), the combination was needed to induce MMP elevation, confirming
the synergistic effect of endotoxin and glucan on airway inflammation (Fogelmark et al.
1994). When WP was combined with LPS, a difference in MMP levels was also observed
in heaves horses’ BALF as compared with levels following saline challenge. Depletion of
endotoxin from HDS and then adding it again did not lead to as clear a decrease in MMPs
as in the neutrophil study (Pirie et al. 2003b), but the reduction in gelatinolytic activity
resulting from depletion of endotoxin was re-established by adding the endotoxin. These
findings support the conjecture that the synergistic effect of dust components is more
potent than the effect of any component alone (Rylander 2001). This method was also
shown to be suitable for demonstration of the synergistic effect of allergens following
inhalation challenge. However, further studies using pure glucan and endotoxin in addition
to crude extracts of HDS are needed to elucidate the roles of these components in inducing
airway inflammation.
In healthy controls, the challenge with SUP, which possesses most of the endotoxin content
of HDS, induced elevated levels of all gelatinolytic activities in BALF, although the
differences did not reach significance. This result contradicts previous findings (Pirie et
al. 2002c), where both HDS and SUP alone induced significant airway neutrophilia in
both groups. The magnitude of the neutrophilic response was higher in heaves horses, but
SUP induced significantly less neutrophilia than HDS in both groups. The composition
of dust has an effect on inflammatory reaction in the airways, as measured by MMP-9.
When dust is divided into fractions, each fraction has only a minor impact on BALF
gelatinolytic MMP levels, but when fractions are combined to form a compound resembling
whole dust, the reaction is more marked. Both the soluble component, which contains
most of the endotoxin in dust, and the particulate component, which contains glucan,
are needed to produce a significant elevation in gelatinolytic MMPs in BALF.
6.8. Direct in vitro activation of MMP-9 by allergens
Direct in vitro activation of MMP-9 by the allergens was investigated using a simple and
novel method in which the proenzyme was incubated with an allergen (AFE-1, AFE-2,
MITE, HDS and its components; SUP, WP and WF) and the resultant conversion of the
92-kDa proMMP-9 to a lower molecular weight (75-85 kDa) activated enzyme form was
measured (III). Previously, cell culture techniques have been used to evaluate the capacity
of various compounds to activate MMPs (Aldonyte et al. 2003; Lamberti et al. 2004).
Our hypothesis was that allergenic compounds could activate the host’s proteolytic enzymes
in addition to their own proteolytic activity (Pirie et al. 2002a,c). Our method did not
apply any cell cultures; instead, the activation was seen as a direct reaction between the
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pure enzyme and the allergen. The method appears to be suitable for in vitro testing of
MMP activation capacity of allergens and showed that AFEs and MITE are the most
potent direct activators of proMMP-9. Although components of HDS (SUP, WP and
WF) efficiently activated proMMP-9, HDS failed to do so at the concentration used.
Reasons for this include low dilution of HDS (1:100 for HDS and SUP versus 1:10 for
WP and WF), which was necessary because of the excessive background activity seen with
higher dilutions in gelatin zymography, and possible inhibitory substances in HDS.
The two AFEs studied were very potent in vitro activators of MMP-9. A. fumigatus has
long been considered one of the main moulds responsible for development of heaves
(McPherson et al. 1979). A. fumigatus also expresses proteolytic enzymes itself (Markaryan
et al. 1996), as do Aspergillus flavus and Fusarium solani. The latter two fungi are reported
to have the capacity to induce expression of MMPs, including MMP-2 and MMP-9, in
infected corneas (Gopinathan et al. 2001). Proteinases secreted by A. fumigatus include
serine proteinases and metalloproteinases (Latgé 1999). A. fumigatus serine proteinase has
been shown to be capable of degrading human lung elastin and human lung type I and
III collagens and causing a significant decrease in lower respiratory tract function of mice
after intranasal installation (Iadrola et al. 1998). So, in addition to allergenic sensitization
of airways, fungi have the capacity to hydrolyse major tissue barriers of the lung, indicating
that equine heaves is not solely a pulmonary hypersensitivity reaction to mould antigens
(McGorum et al. 1993a). There might also be direct damage to lungs that results from
proteolytic activity of allergens, or the fungi might induce conformational changes in
proMMP-9, enhancing its auto-cleavage properties to activate itself (Kähäri and Saarialho-
Kere 1999). These two additional routes of allergen action have both been demonstrated
in vitro in Study III. No association being found between skin testing of common allergens
and development of heaves speaks against pure allergic-type pathogenesis of equine heaves
(Derksen 1993). Inhalation of fungal allergens has been shown in vitro to increase
degranulation of pulmonary equine mast cells, a process suggested to contribute to
pathogenesis of heaves (Hare et al. 1999).
A storage mite suspension was also demonstrated to be an efficient in vitro activator of
MMP-9 (III). There are several different species of storage mites. The species of the mite
used in our study was not determined. The role of mites in development of equine heaves
was suggested by Hockenjos and colleagues in 1981, but it has been studied surprisingly
little since. House dust mites, such as Dermatophagoides pteronyssinus, have proteolytic
activity (including metalloproteinase activity) in their faecal pellets (Winton et al. 1998a).
They produce proteinases of cysteine and serine mechanistic classes that hinder epithelial
adhesion and function in cell culture (Winton et al. 1998b) and induce cytokine production
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from cultured airway epithelium cells (King et al. 1998). In addition, house dust mite
cysteine proteinase is known to catalytically inactivate serine proteinase inhibitor α1-
antitrypsin (Kalsheker et al. 1996). House dust mite allergens can contribute to sensitization
of airways by degrading the function of the airway epithelial barrier (Wan et al. 2000).
The main proteolytic activity of house dust mite extract is largely mediated by its cysteine
proteinase allergen (John et al. 2000). The direct activation capacity demonstrated in
Study III may further enhance airway damage.
6.9. Elevation of gelatinolytic MMPs in calves with microbial respiratory
infection
Production of gelatinolytic MMP-2 and MMP-9 in airways following concurrent Pasteurella
and Mycoplasma sp. respiratory infection in calves was reported for the first time in Study
IV. MMP-2 and MMP-9 were examined from the TBLF of calves with microbial respiratory
infection and control calves. Infection with M. haemolytica has been demonstrated to
result in neutrophil accumulation in the lungs of calves (Slocombe et al. 1985), similar
to equine heaves despite the different aetiologies of these two diseases. In addition, two
recent reports describe elevated levels of MMP-2 and MMP-9 in calf airways, one following
experimental M. haemolytica infection (Starr et al. 2004) and the other showing gelatinolytic
activity in BALF from healthy calves (Lakritz et al. 2004). In Study IV, the active forms
of MMP-2 and MMP-9 were elevated. One explanation for this elevation is the production
of free oxygen radicals, which have been reported to be produced by activated macrophages
and neutrophils during M. haemolytica infection and to cause oxidative damage in lung
tissue (Ackermann and Brogden 2000). Interestingly, free radicals are also known to activate
MMPs, especially proMMP-9 (Weiss 1989; Paquette et al. 2003).
Sources of proteolytic activity in addition to the host have been suggested. These include
bacteria (Maeda and Yamamoto 1996), fungi (Iadrola et al. 1998), dust mites (King et
al. 1998) and pollens (Widmer et al. 2000). In Study IV, gelatinolytic MMPs in bacterial
suspensions of P. multocida were not found. There are, however, reports of proteolytic
enzyme production in various bacterial species, including Pseudomonas aeruginosa elastolytic
enzymes (Braun et al. 1998), Helicobacter pylori MMP-1- and MMP-3-like metalloproteinases
(Göõz et al. 2001), clostridial neurotoxins, Bacteroides fragilis endotoxin, Bacillus anthracis
lethal factor and zinc-dependent metalloproteinases secreted by Vibrio vulnificus, Vibrio
cholerae and Legionella pneumophila (Miyoshi and Shinoda 2000). Bacterial proteinases
from P. aeruginosa were shown to contribute little to the gelatinolytic activity measured
in sputum specimens of humans suffering from cystic fibrosis, even though culture
supernatants from various P. aeruginosa strains expressed in vitro gelatinolytic activity
resulting from bacterial metalloelastase (Delacourt et al. 1995).
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Metalloproteinases and other type of proteinases can, in some cases, be considered virulence
factors for certain pathogens and allergens (Maeda and Yamamoto 1996). Proteolytic
destruction aids inflammatory cell invasion into tissues and may cause direct tissue
destruction. Furthermore, the ability of bacterial metalloproteinases to activate host-
originating metalloproteinases may also have an effect on pathogenesis of infective respiratory
diseases (Sorsa et al. 1992; Maeda and Yamamoto 1996). Other mechanisms of microbial
products serving this purpose include chemotaxis of alveolar macrophages and neutrophils
by, for example, A. fumigatus extract, bacterial proteases and glucans (Milanowski et al.
1995), compounds included in Studies I and IV. Lack of bacterial MMP production in
Study IV might depend on the growth stage of bacterial cells (Braun et al. 1998) or on
the destruction of enzymes during the process of bacterial disintegration. However, viability
of bacterial strains is not always necessary for induction of MMP elevation; heat-inactivated
Streptococcus pneumoniae, for instance, has been shown to increase release of MMP-2 from
endothelial cells (Michel et al. 2001). In Study IV, the results indicate that gelatinolytic
MMPs detected by zymography are host-derived rather than bacteria-derived. This finding
is in line with Gopinathan et al. (2001), who considered the MMP-2 and MMP-9 found
in fungal infection of rabbit cornea to originate from host PMNs rather than from fungi.
A positive association has been reported between increased proportions of neutrophils and
the presence of P. multocida and M. bovis (Allen et al. 1992) as well as M. haemolytica
(Jericho 1989; Narita et al. 2000) in BALF. Previous findings, namely an increase in
neutrophils in Mannheimia and Pasteurella infection, support the role of bovine neutrophils
as a source of MMPs in airway inflammation of calves (IV). Further studies are needed
to determine the role of these proteolytic compounds in the development of respiratory
disease and whether treatment involving inhibition of MMPs can be developed. Identifying
a specific inhibitor of these tissue-destructive processes would be of great value in the fight
against respiratory diseases in calves. The role of neutrophils in the development of lung
lesions has been recognized for more than a decade (Slocombe et al. 1985; Weiss et al.
1991). Research on inhibitors of MMPs also includes chemically modified tetracyclines,
which have been demonstrated to prevent LPS-induced acute respiratory distress sydrome
in a pig model (Carney et al. 2001) and doxicycline, which inhibits MMPs in human
periodontal disease (Golub et al. 1998; Emingil et al. 2004a,b; Sorsa et al. 2004). The
above-mentioned findings raise questions about the mode of action of tetracycline in
pneumonic pasteurellosis: how much of its effectiveness is due to antimicrobial activity
and is there another mechanism that prevents epithelial damage in the lungs by inhibiting
proteolytic enzymes released by neutrophils?
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The diseased calves in Study IV had concurrent Mycoplasma sp. growth in their TBLF,
and some clinically healthy controls as well as diseased calves had positive PCR findings
for M. bovirhinis. The mycoplasma finding was, however, not considered when allocating
the animals because the role of mycoplasma in respiratory disease is not known. In a
Danish study where calves that had died of respiratory disease were submitted to the
laboratory for diagnostic purposes M. bovis  was found in only one case, but M. dispar,
M. bovirhinis and Ureaplasma diversum were present, often concomitantly, in the majority
of cases (in 43 of the 51 lungs examined) (Tegtmeier et al. 1999). Interestingly, when
diseased calves were grouped according to their M. bovirhinis status, in TBLF from calves
with M. bovirhinis infection, in addition to Pasteurella and Mycoplasma sp., gelatinolytic
MMPs were more elevated than in calves with Pasteurella and Mycoplasma sp. infection
only (IV). These results suggest that concurrent M. bovirhinis infection contributes to
more severe tissue destruction in calf pneumonia.
The contribution of endotoxin to airway inflammation was studied in heaves horses (I,
II), but it may also have an effect on calf pasteurellosis (IV), as the main bacterial pathogens
are Gram-negative. Very severe experimental infections of calves with BHV-1 combined
with M. haemolytica have been shown to result in several-fold higher BAL endotoxin levels
than in controls or calves infected with either BHV-1 or M. haemolytica alone (Narita et
al. 2000). M. haemolytica endotoxin clearly has a prominent role in initiating the
inflammatory response in ruminants (Ackermann and Brogden 2000). Endotoxins are
produced by both pathogenic and non-pathogenic bacteria and released during growth
and upon lysis. In addition, potency of endotoxins differs among bacterial species (Carter
and Chengappa 1995b).  Endotoxin used in equine studies (I, II) was isolated from S.
typhimurium.
6.10. Elevation of gelatinolytic MMPs in healthy controls
Normal tissue remodelling in the lungs results in small baseline levels of MMPs in the
BALF of healthy controls (Mautino et al. 1997). Inhaled saline itself can cause minor
irritation, which was also seen in the current studies, with saline challenge causing slightly
elevated amounts of MMPs in BAL samples of control horses (I, II) and in TBL samples
of control calves (IV). There was a large standard deviation in results, especially for healthy
controls. This may, at least in part, be explained by variable sensitivity of individual animals
to challenges, a phenomenon demonstrated in humans as well (Kline et al. 1999). Elevated
levels of MMP-2 and MMP-9 in control animals’ TBLF and BALF suggest the contribution
of other factors, such as viral and mycoplasma infections and environmental irritation,
to lung damage. Inflammatory changes have been reported to occur in both clinically
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diseased and healthy calves, indicating frequent occurrence of subclinical disease (Allen
et al. 1992). In a study by Jolie et al. (1999), pigs in the control group expressed elevated
amounts of MMPs, and the reason was concluded to be increased levels of dust in the
compartment where control animals were held. Poor air quality can cause tissue damage
to airways, increasing the susceptibility to pathogenic microbes. Measured mean dust levels
have been reported to vary from 0.38 mg/m3 to 0.74 mg/m3 in cattle barns (Kullman
et al. 1998; Takai et al. 1998) and from 0.7 mg/m3 to 2.7 mg/m3 in horse stables (Woods
et al. 1993; McGorum et al. 1998). The lower dust levels in cattle barns than in horse
stables may be explained by the use of silage for feed and little or no bedding for cattle.
Dust components are capable of increasing MMP-9 amount and activity in respiratory
secretions in a dose-dependent manner (I), indicating that excessive amounts of dust can
result in respiratory tract epithelium damage that can in part be controlled by reducing
the dose of inhaled dust. Clean source materials, optimal stable design, good management
practices, proper ventilation (Clarke et al. 1987; Clarke 1993; Woods et al. 1993) and
improved conditions for feed production and storage (Kamphues 1996) should be
emphasized to reduce air organic dust levels in stables. Based on the results of Study I and
previous knowledge, even healthy horses can be affected by extremely dusty air.
In the endotoxin dose-dependency study (I), both saline and LPS challenge of 20 μg
elevated the activation percentage of MMP-9 in healthy controls more than in heaves
horses. The same phenomenon was seen following HDS challenge, although the difference
was not statistically significant. The endotoxin concentration in HDS was 21.6 μg/ml,
which is nearly the same concentration as in the 20-μg LPS challenge. The increased
activation percentage of MMP-9 in healthy controls’ as compared with heaves horses’
BALF may be due to priming of airway defence mechanisms in heaves horses. Heaves
horses seem to resist activation of MMP-9 more efficiently than healthy horses when the
airways are challenged with saline or low doses of endotoxin. In healthy horses, the airways
are less prepared for irritation, and thus, elevated MMP levels and activation are detectable
even with saline challenge. This could, at least in part, be explained by increased levels
of tissue inhibitors of MMPs (TIMPs) in heaves horses, which bind active MMPs more
readily. Unfortunately, TIMP levels were not measured in these studies. The roles of TIMP-
1 and TIMP-2 in development of allergic airway disease and following LPS challenge in
airways has been studied widely (Yao et al. 1997; Jean et al. 1998; Gibbs et al. 1999a;
Kumagai et al. 1999; Corbel et al. 2001b), but the complicated balance between MMP
and TIMP levels warrants further research.
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6.11. Differences in gelatinolytic MMPs between allergic and infective
respiratory diseases
MMP-9 was the main MMP to react in equine challenges (I, II). Both the proenzyme
and active forms of MMP-9 in BALF were elevated in response to HDS challenge and
to challenges with combinations of its components. MMP-2 was not significantly elevated
in heaves horses following any of the challenges (I, II). This is in line with previous findings
where MMP-2 was only slightly elevated in heaves horses compared with healthy controls
(Raulo et al. 2001a), and experimental challenges with hay/straw and HDS did not alter
MMP-2 levels in BALF significantly (Nevalainen et al. 2002). In calves, however, MMP-
2 levels were elevated following inflammation (IV). Elevated levels of MMP-2 have also
been detected in BALF of human patients suffering from bronchiectasis (Sepper et al.
1994), non-specific interstitial pneumonia and bronchiolitis obliterans organizing pneumonia
(Suga et al., 2000) and in pigs with PRRSV infection (Girard et al. 2001). Corbel et al.
(2001a) demonstrated an elevation in both MMP-9 and MMP-2 levels in BALF after
chronic exposure to LPS in a murine model. Stimulation of macrophages with LPS
increased both MMP-2 (modestly) and MMP-9 (markedly) production in an acute lung
injury model in vitro and in vivo (Gibbs et al. 1999a,b). Although MMP-2 and MMP-9
seem to increase non-specifically in respiratory inflammations of different aetiologies, there
might be variation in responses to different challenges, as measured by MMPs, depending
on the type of the disease and the species in question. Although allergic COPD-type
respiratory diseases have historically not been considered important in bovine species (von
Fellenberg et al. 1979), farmers have increased prevalence of allergic and toxic respiratory
diseases (farmer’s lung) (Malmberg 1990), and environmental allergen-induced pneumonia
is also recognized in cattle (Pearson 1984). In addition to management differences, variation
may exist between animal species in susceptibility to allergic-type airway diseases, which
may be related to the behaviour of animals and to anatomical and physiological differences.
7. CONCLUSIONS
1. Dose-dependent elevation occurs in BALF MMP-9 levels of heaves-susceptible
and control horses challenged with LPS, HDS and AFE, with the response being
greater in heaves-susceptible horses.
2. Neither of the components alone (WP or SUP) increased MMP-2, MMP-9 or 
total gelatinolytic activity levels, but their combination, which resembles HDS,
produced a significant elevation as compared with saline challenge, indicating
a synergistic effect between soluble (SUP, endotoxin) and particulate (WP, glucan)
components of organic dust.
3. Inhaled AFE and HDS with a high proportion of glucan activated MMP-9
efficiently in vivo, supporting a role for moulds in the activation of MMP-9.
4. AFE activated proMMP-9 more efficiently than HDS or its components (SUP
and WP) in vitro.
5. The calf host response to microbial respiratory infection includes elevation of
active MMP-2 and active MMP-9 in TBLF.
6. MMP-2 and -9 were more elevated in TBLF of diseased calves with concurrent
M. bovirhinis, P. multocida and Mycoplasma sp. infection than in BALF of diseased
calves with only P. multocida and Mycoplasma sp. infection.
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